<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article article-type="research-article" dtd-version="3.0" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLoS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PONE-D-12-36682</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0057043</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Biology</subject>
<subj-group>
<subject>Genetics</subject>
<subj-group>
<subject>Population genetics</subject>
<subj-group>
<subject>Genetic polymorphism</subject>
</subj-group>
</subj-group>
</subj-group>
<subj-group>
<subject>Population biology</subject>
<subj-group>
<subject>Population genetics</subject>
<subj-group>
<subject>Genetic polymorphism</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Medicine</subject>
<subj-group>
<subject>Clinical research design</subject>
<subj-group>
<subject>Meta-analyses</subject>
</subj-group>
</subj-group>
<subj-group>
<subject>Epidemiology</subject>
<subj-group>
<subject>Cancer epidemiology</subject>
</subj-group>
</subj-group>
<subj-group>
<subject>Oncology</subject>
<subj-group>
<subject>Cancers and neoplasms</subject>
<subj-group>
<subject>Gastrointestinal tumors</subject>
<subj-group>
<subject>Hepatocellular carcinoma</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline">
<subject>Genetics and Genomics</subject>
<subject>Public Health and Epidemiology</subject>
<subject>Oncology</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Mathematical and statistical techniques</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Statistics (mathematics)</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Evolutionary biology</subject><subj-group><subject>Population genetics</subject><subj-group><subject>Genetic polymorphism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Population genetics</subject><subj-group><subject>Genetic polymorphism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Population biology</subject><subj-group><subject>Population genetics</subject><subj-group><subject>Genetic polymorphism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and neoplasms</subject><subj-group><subject>Carcinomas</subject><subj-group><subject>Hepatocellular carcinoma</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and neoplasms</subject><subj-group><subject>Gastrointestinal tumors</subject><subj-group><subject>Hepatocellular carcinoma</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Gastroenterology and hepatology</subject><subj-group><subject>Liver diseases</subject><subj-group><subject>Hepatocellular carcinoma</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and places</subject><subj-group><subject>Geographical locations</subject><subj-group><subject>Asia</subject><subj-group><subject>China</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and places</subject><subj-group><subject>Geographical locations</subject><subj-group><subject>Asia</subject><subj-group><subject>Taiwan</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Science policy</subject><subj-group><subject>Research integrity</subject><subj-group><subject>Publication ethics</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Chromatographic techniques</subject><subj-group><subject>Affinity chromatography</subject><subj-group><subject>Amino acid specific chromatography</subject><subj-group><subject>Glutathione chromatography</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and places</subject><subj-group><subject>Geographical locations</subject></subj-group></subj-group></article-categories>
<title-group>
<article-title>Association of <italic>GST</italic> Genetic Polymorphisms with the Susceptibility to Hepatocellular Carcinoma (HCC) in Chinese Population Evaluated by an Updated Systematic Meta-Analysis</article-title>
<alt-title alt-title-type="running-head"><italic>GST</italic> Genetic Polymorphisms and HCC Risk</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Liu</surname>
<given-names>Kui</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Zhang</surname>
<given-names>Lu</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Lin</surname>
<given-names>Xialu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Chen</surname>
<given-names>Liangliang</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Shi</surname>
<given-names>Hongbo</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Magaye</surname>
<given-names>Ruth</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Zou</surname>
<given-names>Baobo</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Zhao</surname>
<given-names>Jinshun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<label>1</label>
<addr-line>Department of Preventative Medicine and Zhejiang Provincial Key Laboratory of Pathological and Physiological Technology, School of Medicine, Ningbo University, Ningbo, Zhejiang Province, People’s Republic of China</addr-line>
</aff>
<aff id="aff2">
<label>2</label>
<addr-line>School of Health Management, Anhui Medical University, Hefei, Anhui Province, People’s Republic of China</addr-line>
</aff>
<aff id="aff3">
<label>3</label>
<addr-line>Yinzhou Peoples’ Hospital, Ningbo University, Ningbo, Zhejiang Province, People’s Republic of China</addr-line>
</aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Coleman</surname>
<given-names>William B.</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1">
<addr-line>University of North Carolina School of Medicine, United States of America</addr-line>
</aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">zhaojinshun@nbu.edu.cn</email></corresp>
<fn fn-type="conflict">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con">
<p>Proof read the manuscript: KL JSZ. Conceived and designed the experiments: JSZ KL LZ. Performed the experiments: KL XLL LLC. Analyzed the data: KL HBS RM BBZ. Contributed reagents/materials/analysis tools: KL JSZ XLL. Wrote the paper: KL JSZ XLL.</p>
</fn>
</author-notes>
<pub-date pub-type="collection">
<year>2013</year>
</pub-date>
<pub-date pub-type="epub">
<day>20</day>
<month>2</month>
<year>2013</year>
</pub-date>
<volume>8</volume>
<issue>2</issue>
<elocation-id>e57043</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>11</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>1</month>
<year>2013</year>
</date>
</history>
<permissions>
<copyright-year>2013</copyright-year>
<copyright-holder>Liu et al</copyright-holder>
<license xlink:type="simple">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Due to the possible involvement of Glutathione <italic>S</italic>-transferase <italic>Mu-</italic>1 (<italic>GSTM1</italic>) and Glutathione <italic>S</italic>-transferase <italic>theta-1</italic> (<italic>GSTT1</italic>) in the detoxification of environmental carcinogens, environmental toxins, and oxidative stress products, genetic polymorphisms of these two genes may play important roles in the susceptibility of human being to hepatocellular carcinoma. However, the existing research results are not conclusive.</p>
</sec>
<sec>
<title>Methods</title>
<p>A systematic literature search using databases (PubMed, Scopus, Embase, Chinese Biomedical Database, Chinese National Knowledge Infrastructure, Wanfang Data, etc.) for the eligible studies meeting the inclusion criteria including case-control studies or cohort studies is evaluated using an updated systematic meta-analysis.</p>
</sec>
<sec>
<title>Results</title>
<p>Significant increase in the risk of HCC in the Chinese population is found in <italic>GSTM1</italic> null genotype (OR = 1.47, 95% CI: 1.21 to 1.79, <italic>P</italic>&lt;0.001) and <italic>GSTT1</italic> null genotype (OR = 1.38, 95% CI: 1.14 to 1.65, <italic>P</italic>&lt;0.001). Analysis using the random-effects model found an increased risk of HCC in <italic>GSTM1-GSTT1</italic> dual null population (OR = 1.79, 95% CI: 1.26 to 2.53, <italic>P</italic>&lt;0.001). In addition, subgroup analyses showed a significant increase in the association of <italic>GST</italic> genetic polymorphisms (<italic>GSTM1</italic>, <italic>GSTT1</italic>, and <italic>GSTM1-GSTT1</italic>) with HCC in southeast and central China mainland. However, available data collected by this study fail to show an association between <italic>GST</italic> genetic polymorphisms and HCC in people from the Taiwan region (for <italic>GSTM1</italic>: OR = 0.78, 95% CI: 0.60 to 1.01, <italic>P</italic> = 0.06; for <italic>GSTT1</italic>: OR = 0.94, 95% CI: 0.78 to 1.14, <italic>P</italic> = 0.546; for <italic>GSTM1-GSTT1</italic>: OR = 1.04, 95% CI: 0.81 to 1.32, <italic>P</italic> = 0.77). Sensitivity analysis and publication bias diagnostics confirmed the reliability and stability of this meta-analysis.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>Our results indicate that both <italic>GSTM1</italic> and <italic>GSTT1</italic> null genotypes are associated with an increased HCC risk in Chinese population. Peoples with dual null genotypes of <italic>GSTM1-GSTT1</italic> are more susceptible to developing HCC. In conclusion, <italic>GST</italic> genetic polymorphisms play vital roles in the development of HCC in the Chinese population.</p>
</sec>
</abstract>
<funding-group>
<funding-statement>Funding provided by grant number: the National Nature Science Foundation of China (Grant No. 81273111), the Foundations of Innovative Research Team of Educational Commission of Zhejiang Province (T200907), the Nature Science Foundation of Ningbo city (Grant No. 2012A610185), the Ningbo Scientific Projects (2012C5019 and SZX11073), the Scientific Innovation Team Project of Ningbo (No. 2011B82014), Innovative Research Team of Ningbo (2009B21002). This work was partly supported by K. C. Wong Magna Fund in Ningbo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<page-count count="13"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Due to a high mortality, hepatocellular carcinoma (HCC) is one of the most serious health problems worldwide <xref ref-type="bibr" rid="pone.0057043-Cabibbo1">[1]</xref>–<xref ref-type="bibr" rid="pone.0057043-Aghemo1">[2]</xref>, which is consisted of approximately 80% of all primary tumors of liver <xref ref-type="bibr" rid="pone.0057043-French1">[3]</xref>. Incidence rates in males and females are listed sixth and ninth as the most common cancers, respectively. Incidence rate of HCC has been increasing for several years while overall cancer incidence rate has been decreasing in recent years <xref ref-type="bibr" rid="pone.0057043-Jemal1">[4]</xref>–<xref ref-type="bibr" rid="pone.0057043-Jemal2">[5]</xref>. Environment and genetic factors are believed to be the pathogenesis of HCC <xref ref-type="bibr" rid="pone.0057043-Annick1">[6]</xref>–<xref ref-type="bibr" rid="pone.0057043-Farazi1">[8]</xref>. Furthermore, previous studies indicated that racial and ethnic variations in the same geographic location could cause result bias in meta-analysis <xref ref-type="bibr" rid="pone.0057043-Wang1">[9]</xref>–<xref ref-type="bibr" rid="pone.0057043-Chen1">[11]</xref>. In Asia, people are at higher risk of developing HCC because of chronic infection with hepatitis B virus (HBV) <xref ref-type="bibr" rid="pone.0057043-Beasley1">[12]</xref>–<xref ref-type="bibr" rid="pone.0057043-McGlynn1">[13]</xref>. In Europe, not only hepatitis C virus (HCV) and cirrhosis, but alcohol and tobacco smoking are also clearly able to accelerate HCC development <xref ref-type="bibr" rid="pone.0057043-Aghemo1">[2]</xref>. Due to its substantial morbidity and mortality, HCC has been a hot research topic in China in recent years.</p>
<p>The Glutathione <italic>S</italic>-transferases (<italic>GSTs</italic>) family is an important phase II isoenzyme which can detoxify environmental carcinogens and toxins, oxidative stress products, and modulate the induction of other enzymes and proteins in the cell at the same time <xref ref-type="bibr" rid="pone.0057043-Udomsinprasert1">[14]</xref>–<xref ref-type="bibr" rid="pone.0057043-Hayes1">[16]</xref>. Enzymes of <italic>GSTs</italic> family are composed of many cytosolic, mitochondrial, and MAPEG proteins. Human <italic>GSTs</italic> can be divided into eight main classes including alpha, mu, pi, theta, sigma, kappa, omega and zeta <xref ref-type="bibr" rid="pone.0057043-Strange1">[17]</xref>. <italic>GSTM1</italic> and <italic>GSTT1</italic> (encoding the Mu and Theta, respectively) both play important roles in human carcinogenesis. Epidemiologic investigations related to genetic association including case-control and cohort studies suggested the association between <italic>GST</italic> genetic polymorphisms and HCC risk. However, some of these studies with sparse data, unreasonable and highly underpowered designs, and differential in research methodology could all inevitably influence the robustness of their results. Meta-analysis can avoid these weaknesses by selecting all eligible studies and reducing random error. To identify the association of <italic>GST</italic> genetic polymorphisms with the susceptibility to hepatocellular carcinoma in the Chinese population, an updated systematic meta-analysis was performed in this study by using a full reference search (from January 1996 to October 2012) and a careful reinvestigation strategy.</p>
</sec>
<sec id="s2" sec-type="methods">
<title>Methods</title>
<sec id="s2a">
<title>1. Literature and Research Strategy</title>
<p>A computerized literature search was carried out in Embase, PubMed, Scopus, Chinese Biomedical Database (CBM), CochraneLibrary, Chinese National Knowledge Infrastructure (CNKI), and Wanfang Data (the latest research was retrospected to October 2012) to collect articles with case-control or cohort studies related to the association of <italic>GSTM1</italic> and/or <italic>GSTT1</italic> polymorphisms with the susceptibility of HCC in China. Meanwhile, reference lists of the relevant articles were also collected. Search was performed through websites of <ext-link ext-link-type="uri" xlink:href="http://www.baidu.com" xlink:type="simple">http://www.baidu.com</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://scholar.google.cn" xlink:type="simple">http://scholar.google.cn</ext-link> to identify additional eligible studies. MeSH terms (“glutathione <italic>S</italic>-transferase” or “<italic>GST</italic>” or “<italic>GSTM1</italic>” or “<italic>GSTT1</italic>”) and (“hepatocellular carcinoma” or “liver cancer” or “HCC”) and (“China” or “Chinese” or “Taiwan”) were used in PubMed. These keyword retrieval strategies were also used in other databases. When there was more than one article published in a same case series, the latest and/or the comprehensive one would be adopted only. Eligible research articles not captured by above research strategies would be further searched by bibliographies.</p>
</sec>
<sec id="s2b">
<title>2. Inclusion and Exclusion Criteria</title>
<p>Inclusion criteria are: (1) case-control and cohort studies, in which individuals or samples used for evaluation of the association between <italic>GST</italic> genetic variances and HCC risk included these owning either with a balance match or not; (2) in the Chinese population; (3) the articles provided raw data including odds ratio (OR) with 95% confidence interval (CI) and respective variance, or the relevant information could be calculated.</p>
<p>Exclusion criteria are: (1) raw data not available for retrieval; (2) multiple articles based on a same population and published by a same research team, only the latest and/or the largest population study was adopted, others would be excluded; (3) meeting abstract, case reports, editorials, review articles and other meta-analysis were exclusive.</p>
</sec>
<sec id="s2c">
<title>3. Data Extraction and Synthesis</title>
<p>To decide inclusively or exclusively, articles were identified by two independent reviewers using a standardized data extraction form designed by our group. Data with discrepancies in identification were discussed. If consensus was not achieved, the decision was made by a third reviewer. Both title and abstract from all potential included articles were screened to identify their relevance. Additionally, if title and abstract were ambiguous, full articles were also investigated. The following information was collected from each study: first author, year of publication, geographical location, study time, pathologic diagnosis, source of control, characteristic of cases and controls, and genotype frequency of null <italic>GSTM1</italic>, <italic>GSTT1</italic> and null of both genotypes in cases and controls.</p>
</sec>
<sec id="s2d">
<title>4. Statistical Analysis</title>
<p>(1) The pooled OR and 95% CI were determined by Z test with <italic>P</italic>&lt;0.05 considered statistically significant; (2) Statistical heterogeneity among studies was assessed with the Q and I<sup>2</sup> statistics <xref ref-type="bibr" rid="pone.0057043-Higgins1">[18]</xref>. The Q test and I<sup>2</sup> were claimed to test the variation which was due to heterogeneity or by random error <xref ref-type="bibr" rid="pone.0057043-HuedoMedina1">[19]</xref>. When <italic>P</italic> value of heterogeneity tests was no more than 0.1 (<italic>P</italic>≤0.1), we used random effects model. When <italic>P</italic> value of heterogeneity test was more than 0.1 (<italic>P</italic>&gt;0.1), we used fixed effects model <xref ref-type="bibr" rid="pone.0057043-Hedges1">[20]</xref>; (3) Sensitivity analysis was also tested by removing one study at a time to calculate the overall homogeneity and effect size; (4) Publication bias was investigated with Beggar’s funnel plot, in which the standard error of log OR of each study was plotted against its OR <xref ref-type="bibr" rid="pone.0057043-Begg1">[21]</xref>; (5) Publication bias was further assessed by the method of Egger’s linear regression test which could assess the relationship between effect size and variance differs between large and small studies <xref ref-type="bibr" rid="pone.0057043-Egger1">[22]</xref>; (6) In this meta-analysis, subgroup analyses were used to better investigate possible reasons of between-study heterogeneity <xref ref-type="bibr" rid="pone.0057043-Higgins2">[23]</xref>. The subgroups are as following: geographical location (southeast and central China mainland, and Taiwan region), number of case (&lt;100 <italic>vs.</italic> ≥100), source of control (population-based <italic>vs.</italic> hospital-based); (7) All analyses were performed using the software State version12.0 (StataCorp LP,College Station,Texas,USA), Review Manager 5.0 (Cochrane collaboration, <ext-link ext-link-type="uri" xlink:href="http://www.cc-ims.net/RevMan/relnotes.htm" xlink:type="simple">http://www.cc-ims.net/RevMan/relnotes.htm</ext-link>). All the <italic>P</italic> values were two sided.</p>
</sec>
</sec>
<sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>1. Study Selection and Study Characteristics</title>
<p>We ultimately identified a total of 27 articles reporting the relationship between <italic>GST</italic> genetic polymorphisms and HCC risk by both Chinese and English database <xref ref-type="bibr" rid="pone.0057043-Hsieh1">[24]</xref>–<xref ref-type="bibr" rid="pone.0057043-Li2">[50]</xref> (<xref ref-type="fig" rid="pone-0057043-g001">Figure 1</xref>). According to the inclusive and exclusive criteria, all articles were retrieved and carefully reviewed to assess the eligibility. The characteristics of the studies including 26 articles of <italic>GSTM1</italic> (3712 cases and 6024 controls), 21 articles of <italic>GSTT1</italic> (3378 cases and 5400 controls) and 12 articles of both <italic>GSTM1</italic> and <italic>GSTT1</italic> (1562 cases and 2537 controls) are shown in <xref ref-type="table" rid="pone-0057043-t001">Table 1</xref>.</p>
<fig id="pone-0057043-g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0057043.g001</object-id>
<label>Figure 1</label>
<caption>
<title>Flow chart of study selection.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0057043.g001" xlink:type="simple"/>
</fig>
<table-wrap id="pone-0057043-t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0057043.t001</object-id>
<label>Table 1</label>
<caption>
<title>Characteristics of the studies related with the effects of <italic>GSTs</italic> genetic polymorphisms and HCC risk.</title>
</caption>
<alternatives>
<graphic id="pone-0057043-t001-1" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0057043.t001" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
</colgroup>
<thead>
<tr>
<td align="left" colspan="1" rowspan="1">No.</td>
<td align="left" colspan="1" rowspan="1">Study (ref.)</td>
<td align="left" colspan="1" rowspan="1">Region</td>
<td align="left" colspan="1" rowspan="1">Study time</td>
<td align="left" colspan="1" rowspan="1">Pathologic diagnosis</td>
<td align="left" colspan="1" rowspan="1">Source of controls</td>
<td align="left" colspan="1" rowspan="1">Case group</td>
<td align="left" colspan="1" rowspan="1">Control group</td>
<td align="left" colspan="3" rowspan="1">Null <italic>GSTM1</italic>/Group number</td>
<td align="left" colspan="3" rowspan="1">Null <italic>GSTT1</italic>/Group number</td>
<td align="left" colspan="2" rowspan="1">Dual Null/Group number</td>
<td align="left" colspan="1" rowspan="1">Overlapped (ref.)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">case</td>
<td align="left" colspan="2" rowspan="1">control</td>
<td align="left" colspan="1" rowspan="1">case</td>
<td align="left" colspan="2" rowspan="1">control</td>
<td align="left" colspan="1" rowspan="1">case</td>
<td align="left" colspan="1" rowspan="1">control</td>
<td align="left" colspan="1" rowspan="1"/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1"><xref ref-type="table-fn" rid="nt102">*</xref>1</td>
<td align="left" colspan="1" rowspan="1">Hsieh LL 1996(<xref ref-type="bibr" rid="pone.0057043-Hsieh1">[24]</xref>)</td>
<td align="left" colspan="1" rowspan="1">Taiwan</td>
<td align="left" colspan="1" rowspan="1">1990–1992</td>
<td align="left" colspan="1" rowspan="1">ALL</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">46 male caseswith HBsAg (+)</td>
<td align="left" colspan="1" rowspan="1">88 male controls with HBsAg (+) matchedon age</td>
<td align="left" colspan="1" rowspan="1">25/46</td>
<td align="left" colspan="2" rowspan="1">47/88</td>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="2" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><xref ref-type="table-fn" rid="nt103">̂</xref>2</td>
<td align="left" colspan="1" rowspan="1">Bian JC 1996(<xref ref-type="bibr" rid="pone.0057043-Bian1">[25]</xref>)</td>
<td align="left" colspan="1" rowspan="1">Zhejiang,etc.</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">ALL</td>
<td align="left" colspan="1" rowspan="1">Population</td>
<td align="left" colspan="1" rowspan="1">65 cases</td>
<td align="left" colspan="1" rowspan="1">106 healthy controls</td>
<td align="left" colspan="1" rowspan="1">44/65</td>
<td align="left" colspan="2" rowspan="1">50/106</td>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="2" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><xref ref-type="table-fn" rid="nt103">̂</xref>3</td>
<td align="left" colspan="1" rowspan="1">Hu Y 1997(<xref ref-type="bibr" rid="pone.0057043-Hu1">[26]</xref>)</td>
<td align="left" colspan="1" rowspan="1">Jiangsu</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Population</td>
<td align="left" colspan="1" rowspan="1">45 cases</td>
<td align="left" colspan="1" rowspan="1">147 healthy controls without consanguineous relationship</td>
<td align="left" colspan="1" rowspan="1">37/45</td>
<td align="left" colspan="2" rowspan="1">75/147</td>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="2" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><xref ref-type="table-fn" rid="nt103">̂</xref>4</td>
<td align="left" colspan="1" rowspan="1">Dong CH 1997(<xref ref-type="bibr" rid="pone.0057043-Dong1">[27]</xref>)</td>
<td align="left" colspan="1" rowspan="1">Hebei, etc.</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Hospital</td>
<td align="left" colspan="1" rowspan="1">110 cases</td>
<td align="left" colspan="1" rowspan="1">112 controls</td>
<td align="left" colspan="1" rowspan="1">62/110</td>
<td align="left" colspan="2" rowspan="1">50/112</td>
<td align="left" colspan="1" rowspan="1">63/110</td>
<td align="left" colspan="2" rowspan="1">42/112</td>
<td align="left" colspan="1" rowspan="1">36/110</td>
<td align="left" colspan="1" rowspan="1">20/112</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="bibr" rid="pone.0057043-Deng2">[58]</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><xref ref-type="table-fn" rid="nt102">*</xref>5</td>
<td align="left" colspan="1" rowspan="1">Dong CH 1998(<xref ref-type="bibr" rid="pone.0057043-Dong2">[28]</xref>)</td>
<td align="left" colspan="1" rowspan="1">Jiangsu</td>
<td align="left" colspan="1" rowspan="1">1996</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Population</td>
<td align="left" colspan="1" rowspan="1">64 cases</td>
<td align="left" colspan="1" rowspan="1">64 healthy controls, matched on age and sex</td>
<td align="left" colspan="1" rowspan="1">29/56</td>
<td align="left" colspan="2" rowspan="1">24/58</td>
<td align="left" colspan="1" rowspan="1">33/56</td>
<td align="left" colspan="2" rowspan="1">23/58</td>
<td align="left" colspan="1" rowspan="1">21/56</td>
<td align="left" colspan="1" rowspan="1">9/58</td>
<td align="left" colspan="1" rowspan="1"/>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><xref ref-type="table-fn" rid="nt102">*</xref>6</td>
<td align="left" colspan="1" rowspan="1">Yu MW 1999(<xref ref-type="bibr" rid="pone.0057043-Yu2">[29]</xref>)</td>
<td align="left" colspan="1" rowspan="1">Taiwan</td>
<td align="left" colspan="1" rowspan="1">1988–1996</td>
<td align="left" colspan="1" rowspan="1">PARTIAL</td>
<td align="left" colspan="1" rowspan="1">Population</td>
<td align="left" colspan="1" rowspan="1">84 cases (81HBsAg (+))</td>
<td align="left" colspan="1" rowspan="1">375 controls (153 HBsAg (−) and 222 HBsAg (+) ), matched on age etc</td>
<td align="left" colspan="1" rowspan="1">42/84</td>
<td align="left" colspan="2" rowspan="1">216/375</td>
<td align="left" colspan="1" rowspan="1">41/83</td>
<td align="left" colspan="2" rowspan="1">181/375</td>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"><xref ref-type="bibr" rid="pone.0057043-Yu4">[59]</xref>–<xref ref-type="bibr" rid="pone.0057043-Yu5">[61]</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><xref ref-type="table-fn" rid="nt102">*</xref>7</td>
<td align="left" colspan="1" rowspan="1">Bian JC 2000(<xref ref-type="bibr" rid="pone.0057043-Bian2">[30]</xref>)</td>
<td align="left" colspan="1" rowspan="1">Jiangsu, etc.</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">ALL</td>
<td align="left" colspan="1" rowspan="1">Population</td>
<td align="left" colspan="1" rowspan="1">63 cases(47male)</td>
<td align="left" colspan="1" rowspan="1">88 healthy controls (67male), without consanguineous relationship</td>
<td align="left" colspan="1" rowspan="1">36/63</td>
<td align="left" colspan="2" rowspan="1">37/88</td>
<td align="left" colspan="1" rowspan="1">8/63</td>
<td align="left" colspan="2" rowspan="1">33/88</td>
<td align="left" colspan="1" rowspan="1">1/63</td>
<td align="left" colspan="1" rowspan="1">16/88</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="bibr" rid="pone.0057043-Bian3">[62]</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><xref ref-type="table-fn" rid="nt102">*</xref>8</td>
<td align="left" colspan="1" rowspan="1">Ma Y 2001(<xref ref-type="bibr" rid="pone.0057043-Ma1">[31]</xref>)</td>
<td align="left" colspan="1" rowspan="1">Guangxi</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">ALL</td>
<td align="left" colspan="1" rowspan="1">Population</td>
<td align="left" colspan="1" rowspan="1">120 cases</td>
<td align="left" colspan="1" rowspan="1">100 healthy controls without any tumors, matched on age and sex</td>
<td align="left" colspan="1" rowspan="1">71/120</td>
<td align="left" colspan="2" rowspan="1">52/100</td>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="2" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><xref ref-type="table-fn" rid="nt103">̂</xref>9</td>
<td align="left" colspan="1" rowspan="1">Wu HL 2000(<xref ref-type="bibr" rid="pone.0057043-Wu1">[32]</xref>)</td>
<td align="left" colspan="1" rowspan="1">Hunan</td>
<td align="left" colspan="1" rowspan="1">1997–1999</td>
<td align="left" colspan="1" rowspan="1">ALL</td>
<td align="left" colspan="1" rowspan="1">Population</td>
<td align="left" colspan="1" rowspan="1">54 cases(46 male)</td>
<td align="left" colspan="1" rowspan="1">136 healthy controls</td>
<td align="left" colspan="1" rowspan="1">38/54</td>
<td align="left" colspan="2" rowspan="1">62/136</td>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="2" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><xref ref-type="table-fn" rid="nt103">̂</xref>10</td>
<td align="left" colspan="1" rowspan="1">Zhu WC 2001(<xref ref-type="bibr" rid="pone.0057043-Zhu1">[33]</xref>)</td>
<td align="left" colspan="1" rowspan="1">Guangdong</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">ALL</td>
<td align="left" colspan="1" rowspan="1">Population</td>
<td align="left" colspan="1" rowspan="1">52 cases</td>
<td align="left" colspan="1" rowspan="1">100 healthy controls equally comparable in sex, age, birthplace and ethnicity</td>
<td align="left" colspan="1" rowspan="1">34/52</td>
<td align="left" colspan="2" rowspan="1">41/100</td>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="2" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><xref ref-type="table-fn" rid="nt102">*</xref>11</td>
<td align="left" colspan="1" rowspan="1">Sun CA 2001(<xref ref-type="bibr" rid="pone.0057043-Sun1">[34]</xref>)</td>
<td align="left" colspan="1" rowspan="1">Taiwan</td>
<td align="left" colspan="1" rowspan="1">1991–1997</td>
<td align="left" colspan="1" rowspan="1">PARTIAL</td>
<td align="left" colspan="1" rowspan="1">Population</td>
<td align="left" colspan="1" rowspan="1">79 cases withHBsAg (+)</td>
<td align="left" colspan="1" rowspan="1">149 controls with HBsAg (+), matched on age, sex, residential township etc</td>
<td align="left" colspan="1" rowspan="1">26/69</td>
<td align="left" colspan="2" rowspan="1">77/128</td>
<td align="left" colspan="1" rowspan="1">30/67</td>
<td align="left" colspan="2" rowspan="1">77/128</td>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="bibr" rid="pone.0057043-Sun2">[63]</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><xref ref-type="table-fn" rid="nt103">̂</xref>12</td>
<td align="left" colspan="1" rowspan="1">Liu CZ 2002(<xref ref-type="bibr" rid="pone.0057043-Liu1">[35]</xref>)</td>
<td align="left" colspan="1" rowspan="1">Shanghai, etc.</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">ALL</td>
<td align="left" colspan="1" rowspan="1">Population</td>
<td align="left" colspan="1" rowspan="1">84 cases</td>
<td align="left" colspan="1" rowspan="1">144 healthy controls, equally comparable in age and birthplace, but not in sex</td>
<td align="left" colspan="1" rowspan="1">56/84</td>
<td align="left" colspan="2" rowspan="1">69/144</td>
<td align="left" colspan="1" rowspan="1">34/84</td>
<td align="left" colspan="2" rowspan="1">36/144</td>
<td align="left" colspan="1" rowspan="1">23/84</td>
<td align="left" colspan="1" rowspan="1">19/144</td>
<td align="left" colspan="1" rowspan="1"/>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><xref ref-type="table-fn" rid="nt103">̂</xref>13</td>
<td align="left" colspan="1" rowspan="1">Liu ZG 2003(<xref ref-type="bibr" rid="pone.0057043-Liu2">[36]</xref>)</td>
<td align="left" colspan="1" rowspan="1">Guangxi</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">ALL</td>
<td align="left" colspan="1" rowspan="1">Population</td>
<td align="left" colspan="1" rowspan="1">51 cases</td>
<td align="left" colspan="1" rowspan="1">53 healthy controls without any tumors,equally comparable in age and sex</td>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="2" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">28/51</td>
<td align="left" colspan="2" rowspan="1">18/53</td>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><xref ref-type="table-fn" rid="nt102">*</xref>14</td>
<td align="left" colspan="1" rowspan="1">Yu MW 2003(<xref ref-type="bibr" rid="pone.0057043-Yu3">[37]</xref>)</td>
<td align="left" colspan="1" rowspan="1">Taiwan</td>
<td align="left" colspan="1" rowspan="1">1997–2001</td>
<td align="left" colspan="1" rowspan="1">PARTIAL</td>
<td align="left" colspan="1" rowspan="1">Population</td>
<td align="left" colspan="1" rowspan="1">577 caseswith HBsAg (+)</td>
<td align="left" colspan="1" rowspan="1">389 controls with HBsAg (+), matched on age and sex</td>
<td align="left" colspan="1" rowspan="1">322/577</td>
<td align="left" colspan="2" rowspan="1">231/389</td>
<td align="left" colspan="1" rowspan="1">298/577</td>
<td align="left" colspan="2" rowspan="1">199/389</td>
<td align="left" colspan="1" rowspan="1">171/577</td>
<td align="left" colspan="1" rowspan="1">116/389</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="bibr" rid="pone.0057043-Chen2">[51]</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><xref ref-type="table-fn" rid="nt102">*</xref>15</td>
<td align="left" colspan="1" rowspan="1">McGlynn KA 2003(<xref ref-type="bibr" rid="pone.0057043-McGlynn2">[38]</xref>)</td>
<td align="left" colspan="1" rowspan="1">Jiangsu</td>
<td align="left" colspan="1" rowspan="1">1992–1993</td>
<td align="left" colspan="1" rowspan="1">PARTIAL</td>
<td align="left" colspan="1" rowspan="1">Population</td>
<td align="left" colspan="1" rowspan="1">231 cases (73%HBsAg (+))</td>
<td align="left" colspan="1" rowspan="1">256 controls matched on age, sex and township of residence</td>
<td align="left" colspan="3" rowspan="1">OR (95% CI) = 0.83 (0.57, 1.21)<xref ref-type="table-fn" rid="nt104">§</xref></td>
<td align="left" colspan="3" rowspan="1">OR(95% CI) = 0.88 (0.59, 1.31)<xref ref-type="table-fn" rid="nt104">§</xref></td>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><xref ref-type="table-fn" rid="nt103">̂</xref>16</td>
<td align="left" colspan="1" rowspan="1">Li SP 2004(<xref ref-type="bibr" rid="pone.0057043-Li1">[39]</xref>)</td>
<td align="left" colspan="1" rowspan="1">Jiangsu</td>
<td align="left" colspan="1" rowspan="1">1998–2002</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Population</td>
<td align="left" colspan="1" rowspan="1">207 cases</td>
<td align="left" colspan="1" rowspan="1">207 healthy controls, matched on sex, age and residence</td>
<td align="left" colspan="2" rowspan="1">122/207</td>
<td align="left" colspan="1" rowspan="1">118/207</td>
<td align="left" colspan="2" rowspan="1">108/207</td>
<td align="left" colspan="1" rowspan="1">97/207</td>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><xref ref-type="table-fn" rid="nt103">̂</xref>17</td>
<td align="left" colspan="1" rowspan="1">He SJ 2004(<xref ref-type="bibr" rid="pone.0057043-He1">[40]</xref>)</td>
<td align="left" colspan="1" rowspan="1">Guangxi</td>
<td align="left" colspan="1" rowspan="1">2001–2002</td>
<td align="left" colspan="1" rowspan="1">ALL</td>
<td align="left" colspan="1" rowspan="1">Population</td>
<td align="left" colspan="1" rowspan="1">105 HCC cases</td>
<td align="left" colspan="1" rowspan="1">151 healthy controls equally comparable in age, sex, ethnicity</td>
<td align="left" colspan="2" rowspan="1">68/105</td>
<td align="left" colspan="1" rowspan="1">77/151</td>
<td align="left" colspan="2" rowspan="1">43/105</td>
<td align="left" colspan="1" rowspan="1">50/151</td>
<td align="left" colspan="1" rowspan="1">30/105</td>
<td align="left" colspan="1" rowspan="1">31/151</td>
<td align="left" colspan="1" rowspan="1"><xref ref-type="bibr" rid="pone.0057043-He2">[64]</xref>, <xref ref-type="bibr" rid="pone.0057043-He3">[65]</xref>, <xref ref-type="bibr" rid="pone.0057043-He4">[66]</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><xref ref-type="table-fn" rid="nt103">̂</xref>18</td>
<td align="left" colspan="1" rowspan="1">Guo HY 2005(<xref ref-type="bibr" rid="pone.0057043-Guo1">[41]</xref>)</td>
<td align="left" colspan="1" rowspan="1">Henan</td>
<td align="left" colspan="1" rowspan="1">1999–2002</td>
<td align="left" colspan="1" rowspan="1">PARTIAL</td>
<td align="left" colspan="1" rowspan="1">Population</td>
<td align="left" colspan="1" rowspan="1">95 HCC cases</td>
<td align="left" colspan="1" rowspan="1">103 healthy controls equallycomparable in age, sex, residence</td>
<td align="left" colspan="2" rowspan="1">67/95</td>
<td align="left" colspan="1" rowspan="1">52/103</td>
<td align="left" colspan="2" rowspan="1">58/95</td>
<td align="left" colspan="1" rowspan="1">45/103</td>
<td align="left" colspan="1" rowspan="1">39/95</td>
<td align="left" colspan="1" rowspan="1">21/103</td>
<td align="left" colspan="1" rowspan="1"/>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><xref ref-type="table-fn" rid="nt103">̂</xref>19</td>
<td align="left" colspan="1" rowspan="1">Ma DL 2005(<xref ref-type="bibr" rid="pone.0057043-Ma2">[42]</xref>)</td>
<td align="left" colspan="1" rowspan="1">Guangxi</td>
<td align="left" colspan="1" rowspan="1">2003–2004</td>
<td align="left" colspan="1" rowspan="1">ALL</td>
<td align="left" colspan="1" rowspan="1">Population</td>
<td align="left" colspan="1" rowspan="1">62 cases withHBsAg (+)</td>
<td align="left" colspan="1" rowspan="1">73 controls with HBsAg (+), without any tumor,equally comparable in age and sex</td>
<td align="left" colspan="2" rowspan="1">37/62</td>
<td align="left" colspan="1" rowspan="1">29/73</td>
<td align="left" colspan="2" rowspan="1">35/62</td>
<td align="left" colspan="1" rowspan="1">21/73</td>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><xref ref-type="table-fn" rid="nt102">*</xref>20</td>
<td align="left" colspan="1" rowspan="1">Long XD 2005(<xref ref-type="bibr" rid="pone.0057043-Long1">[43]</xref>)</td>
<td align="left" colspan="1" rowspan="1">Guangxi</td>
<td align="left" colspan="1" rowspan="1">2002–2003</td>
<td align="left" colspan="1" rowspan="1">ALL</td>
<td align="left" colspan="1" rowspan="1">Hospital</td>
<td align="left" colspan="1" rowspan="1">140 cases</td>
<td align="left" colspan="1" rowspan="1">536 controls without any tumor,equally comparable in sex, age, ethnicity</td>
<td align="left" colspan="2" rowspan="1">92/140</td>
<td align="left" colspan="1" rowspan="1">254/536</td>
<td align="left" colspan="2" rowspan="1">82/140</td>
<td align="left" colspan="1" rowspan="1">234/536</td>
<td align="left" colspan="1" rowspan="1">60/140</td>
<td align="left" colspan="1" rowspan="1">127/536</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="bibr" rid="pone.0057043-Long3">[67]</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><xref ref-type="table-fn" rid="nt102">*</xref>21</td>
<td align="left" colspan="1" rowspan="1">Deng ZL 2005(<xref ref-type="bibr" rid="pone.0057043-Deng1">[44]</xref>)</td>
<td align="left" colspan="1" rowspan="1">Guangxi</td>
<td align="left" colspan="1" rowspan="1">1998–2002</td>
<td align="left" colspan="1" rowspan="1">ALL</td>
<td align="left" colspan="1" rowspan="1">Population</td>
<td align="left" colspan="1" rowspan="1">181 cases</td>
<td align="left" colspan="1" rowspan="1">360 controls without any tumor</td>
<td align="left" colspan="2" rowspan="1">117/181</td>
<td align="left" colspan="1" rowspan="1">172/360</td>
<td align="left" colspan="2" rowspan="1">108/181</td>
<td align="left" colspan="1" rowspan="1">154/360</td>
<td align="left" colspan="1" rowspan="1">38.2%</td>
<td align="left" colspan="1" rowspan="1">18.5%</td>
<td align="left" colspan="1" rowspan="1"><xref ref-type="bibr" rid="pone.0057043-Deng3">[68]</xref>, <xref ref-type="bibr" rid="pone.0057043-Wei2">[69]</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><xref ref-type="table-fn" rid="nt102">*</xref>22</td>
<td align="left" colspan="1" rowspan="1">Long XD 2006(<xref ref-type="bibr" rid="pone.0057043-Long2">[45]</xref>)</td>
<td align="left" colspan="1" rowspan="1">Guangxi</td>
<td align="left" colspan="1" rowspan="1">2004–2005</td>
<td align="left" colspan="1" rowspan="1">ALL</td>
<td align="left" colspan="1" rowspan="1">Population</td>
<td align="left" colspan="1" rowspan="1">257 cases</td>
<td align="left" colspan="1" rowspan="1">649 controls without clinical evidence of liver disease,matched on age, sex, ethnicityand HBV infection</td>
<td align="left" colspan="2" rowspan="1">179/257</td>
<td align="left" colspan="1" rowspan="1">312/649</td>
<td align="left" colspan="2" rowspan="1">146/257</td>
<td align="left" colspan="1" rowspan="1">297/649</td>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><xref ref-type="table-fn" rid="nt103">̂</xref>23</td>
<td align="left" colspan="1" rowspan="1">Yang ZG 2009(<xref ref-type="bibr" rid="pone.0057043-Yang1">[46]</xref>)</td>
<td align="left" colspan="1" rowspan="1">Guangxi</td>
<td align="left" colspan="1" rowspan="1">2002–2008</td>
<td align="left" colspan="1" rowspan="1">ALL</td>
<td align="left" colspan="1" rowspan="1">Population</td>
<td align="left" colspan="1" rowspan="1">100 cases</td>
<td align="left" colspan="1" rowspan="1">60 healthy controls withouthepatitis virus infection, tumorsand AFP negative, equally comparable in age and sex</td>
<td align="left" colspan="2" rowspan="1">59/100</td>
<td align="left" colspan="1" rowspan="1">41/60</td>
<td align="left" colspan="2" rowspan="1">33/100</td>
<td align="left" colspan="1" rowspan="1">11/60</td>
<td align="left" colspan="1" rowspan="1">22/100</td>
<td align="left" colspan="1" rowspan="1">2/60</td>
<td align="left" colspan="1" rowspan="1"/>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><xref ref-type="table-fn" rid="nt102">*</xref>24</td>
<td align="left" colspan="1" rowspan="1">Kao CC 2010(<xref ref-type="bibr" rid="pone.0057043-Kao1">[47]</xref>)</td>
<td align="left" colspan="1" rowspan="1">Taiwan</td>
<td align="left" colspan="1" rowspan="1">2006–2008</td>
<td align="left" colspan="1" rowspan="1">ALL</td>
<td align="left" colspan="1" rowspan="1">Population</td>
<td align="left" colspan="1" rowspan="1">102 cases</td>
<td align="left" colspan="1" rowspan="1">386 healthy controls, matched onethnicity, sex and residential area</td>
<td align="left" colspan="2" rowspan="1">54/102</td>
<td align="left" colspan="1" rowspan="1">211/386</td>
<td align="left" colspan="2" rowspan="1">51/102</td>
<td align="left" colspan="1" rowspan="1">200/386</td>
<td align="left" colspan="1" rowspan="1">31/102</td>
<td align="left" colspan="1" rowspan="1">104/386</td>
<td align="left" colspan="1" rowspan="1"/>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><xref ref-type="table-fn" rid="nt102">*</xref>25</td>
<td align="left" colspan="1" rowspan="1">Wei YP 2012(<xref ref-type="bibr" rid="pone.0057043-Wei1">[48]</xref>)</td>
<td align="left" colspan="1" rowspan="1">Guangxi</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">ALL</td>
<td align="left" colspan="1" rowspan="1">Hospital</td>
<td align="left" colspan="1" rowspan="1">181 cases (78.5%HBsAg (+))</td>
<td align="left" colspan="1" rowspan="1">641 controls (9.8%HBsAg (+))without cancer disease, matched on age and sex</td>
<td align="left" colspan="2" rowspan="1">118/181</td>
<td align="left" colspan="1" rowspan="1">305/641</td>
<td align="left" colspan="2" rowspan="1">104/181</td>
<td align="left" colspan="1" rowspan="1">276/641</td>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="bibr" rid="pone.0057043-Wei3">[70]</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><xref ref-type="table-fn" rid="nt103">̂</xref>26</td>
<td align="left" colspan="1" rowspan="1">Tang YT 2012(<xref ref-type="bibr" rid="pone.0057043-Tang1">[49]</xref>)</td>
<td align="left" colspan="1" rowspan="1">Guangxi</td>
<td align="left" colspan="1" rowspan="1">2008–2010</td>
<td align="left" colspan="1" rowspan="1">ALL</td>
<td align="left" colspan="1" rowspan="1">Population</td>
<td align="left" colspan="1" rowspan="1">150 malecases</td>
<td align="left" colspan="1" rowspan="1">150 male healthy controls, equallycomparable in age</td>
<td align="left" colspan="2" rowspan="1">76/150</td>
<td align="left" colspan="1" rowspan="1">77/150</td>
<td align="left" colspan="2" rowspan="1">63/150</td>
<td align="left" colspan="1" rowspan="1">68/150</td>
<td align="left" colspan="1" rowspan="1">30/150</td>
<td align="left" colspan="1" rowspan="1">32/150</td>
<td align="left" colspan="1" rowspan="1"/>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><xref ref-type="table-fn" rid="nt102">*</xref>27</td>
<td align="left" colspan="1" rowspan="1">Ling CG 2012(<xref ref-type="bibr" rid="pone.0057043-Li2">[50]</xref>)</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">2005–2007</td>
<td align="left" colspan="1" rowspan="1">ALL</td>
<td align="left" colspan="1" rowspan="1">Population</td>
<td align="left" colspan="1" rowspan="1">476 cases (54.7%HBsAg (+), 13.4%Anti-HCV (+))</td>
<td align="left" colspan="1" rowspan="1">481 controls (43.6%HBsAg (+), 2.5%Anti-HCV (+)), withoutmalignancy diseases etc., equally comparable in age and sex</td>
<td align="left" colspan="2" rowspan="1">244/476</td>
<td align="left" colspan="1" rowspan="1">211/481</td>
<td align="left" colspan="2" rowspan="1">120/476</td>
<td align="left" colspan="1" rowspan="1">94/481</td>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="nt101">
<label/>
<p>ALL: HCC cases were confirmed by pathologic diagnosis; PARTIAL: part of HCC cases were confirmed by pathologic diagnosis; NA: relative data were not available in original studies;</p>
</fn>
<fn id="nt102">
<label>*</label>
<p>Articles published in English;</p>
</fn>
<fn id="nt103">
<label>̂</label>
<p>Articles published in Chinese.</p>
</fn>
<fn id="nt104">
<label>§</label>
<p>McGlynn et al. did not show genotype frequency of cases and controls, but presented OR with 95% CI;</p>
</fn>
<fn id="nt105">
<label/>
<p>Southeast regions in China mainland include Hebei, Shanghai, Jiangsu, Zhejiang, Anhui, Jiangxi, and Guangxi. Central regions in China mainland include Hunan and Henan.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3b">
<title>2. Meta-analysis Results</title>
<sec id="s3b1">
<title>2.1. <italic>GSTM1</italic> null genotype with HCC risk</title>
<p>26 articles [24–35, and 37–50] including 3712 cases and 6024 controls were investigated in this study to evaluate the association between <italic>GSTM1</italic> null genotype and HCC susceptibility. 12 articles were published in Chinese and 14 articles in English. Results obtained from a random-effects model showed a significant association between the <italic>GSTM1</italic> null genotype and HCC risk in the Chinese population (OR = 1.47, 95% CI: 1.21 to 1.79, <italic>P</italic>&lt;0.001). The forest plot was showed in <xref ref-type="fig" rid="pone-0057043-g002">Figure 2</xref>.</p>
<fig id="pone-0057043-g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0057043.g002</object-id>
<label>Figure 2</label>
<caption>
<title>Association between <italic>GSTM1</italic> null genotype and HCC risk analyzed by forest plot of meta-analysis.</title>
<p>The forest plots of pooled OR with 95% CI (Null genotype <italic>vs.</italic> Present genotype; OR = 1.47, 95% CI: 1.21 to 1.79; Random-effects model, <italic>P</italic>&lt;0.001).</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0057043.g002" xlink:type="simple"/>
</fig>
</sec>
<sec id="s3b2">
<title>2.2. <italic>GSTT1</italic> null genotype with HCC risk</title>
<p>21 articles including 3378 cases and 5400 controls were used for the investigation of the association between <italic>GSTT1</italic> null genotype and HCC susceptibility. 9 articles were published in Chinese and 12 articles were published in English. Results showed that the <italic>GSTM1</italic> null genotype was significantly associated with HCC risk demonstrated by random-effects model in the Chinese population (OR = 1.38, 95% CI: 1.14 to 1.65, <italic>P</italic>&lt;0.001). The forest plot was shown in <xref ref-type="fig" rid="pone-0057043-g003">Figure 3</xref>.</p>
<fig id="pone-0057043-g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0057043.g003</object-id>
<label>Figure 3</label>
<caption>
<title>Association between <italic>GSTT1</italic> null genotype and HCC risk analyzed by forest plot of meta-analysis.</title>
<p>The forest plots of pooled OR with 95% CI (Null genotype <italic>vs.</italic> Present genotype; OR = 1.38, 95% CI: 1.14 to 1.65; Random-effects model, <italic>P</italic>&lt;0.001).</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0057043.g003" xlink:type="simple"/>
</fig>
</sec>
<sec id="s3b3">
<title>2.3. Dual-null genotype of <italic>GSTM1-GSTT1</italic> with HCC risk</title>
<p>12 articles (6 articles in Chinese and 6 articles in English) including 1763 cases and 2537 controls were used to evaluate the relationship between <italic>GSTM1-GSTT1</italic> null genotype and HCC susceptibility. Results indicated that dual-null genotype of <italic>GSTM1-GSTT1</italic> also had a significant association with HCC risk in the Chinese population (OR = 1.79, 95% CI: 1.26 to 2.53, <italic>P</italic>&lt;0.001). The forest plot was shown in <xref ref-type="fig" rid="pone-0057043-g004">Figure 4</xref>.</p>
<fig id="pone-0057043-g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0057043.g004</object-id>
<label>Figure 4</label>
<caption>
<title>Association between <italic>GSTM1-GSTT1</italic> dual-null genotype and HCC risk analyzed by forest plot of meta-analysis.</title>
<p>The forest plots of pooled OR with 95% CI (Dual-null genotype <italic>vs.</italic> Present genotype; OR = 1.79, 95% CI: 1.26 to 2.53; Random-effects model, <italic>P</italic>&lt;0.001).</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0057043.g004" xlink:type="simple"/>
</fig>
</sec>
</sec>
<sec id="s3c">
<title>3. Subgroup Analysis</title>
<p>The substantial between-study heterogeneity of the three above analyses were observed (<italic>P</italic> values for <italic>GSTM1</italic>, <italic>GSTT1</italic>, and the interaction of <italic>GSTM1-GSTT1</italic> were all less than 0.001, I<sup>2</sup> values were 77.4%, 71.1%, and 77.7%, respectively). In this meta-analysis, subgroup analyses contained geographical location (southeast regions in China mainland, central regions in China mainland, and Taiwan region), case number (&lt;100 <italic>vs.</italic> ≥100), source of control (population-based <italic>vs.</italic> hospital-based). The between-study heterogeneity showed that the major source of heterogeneity came from China mainland population. Association between <italic>GST</italic> genetic polymorphisms and HCC risk increase was significant in subgroup analyses of both southeast and central regions in China mainland population, but no significant in Taiwan population. Other subgroup analyses results were shown in <xref ref-type="table" rid="pone-0057043-t002">Table 2</xref>, <xref ref-type="table" rid="pone-0057043-t003">Table 3</xref>, and <xref ref-type="table" rid="pone-0057043-t004">Table 4</xref>.</p>
<table-wrap id="pone-0057043-t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0057043.t002</object-id>
<label>Table 2</label>
<caption>
<title>Subgroup analysis of the association between <italic>GSTM1</italic> null genotype and HCC risk.</title>
</caption>
<alternatives>
<graphic id="pone-0057043-t002-2" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0057043.t002" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
</colgroup>
<thead>
<tr>
<td align="left" colspan="1" rowspan="1">Polymorphism</td>
<td align="left" colspan="1" rowspan="1">Null <italic>vs</italic>. Present</td>
<td align="left" colspan="1" rowspan="1">No. of studies (cases/controls)</td>
<td align="left" colspan="2" rowspan="1">Odds ratio</td>
<td align="left" colspan="1" rowspan="1">M</td>
<td align="left" colspan="2" rowspan="1">Heterogeneity</td>
<td align="left" colspan="1" rowspan="1">
<italic>P<sub>E</sub></italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">OR [95% CI]</td>
<td align="left" colspan="1" rowspan="1">
<italic>POR</italic>
</td>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">I<sup>2</sup> (%)</td>
<td align="left" colspan="1" rowspan="1">
<italic>PH</italic>
</td>
<td align="left" colspan="1" rowspan="1"/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>GSTM1</italic>
</td>
<td align="left" colspan="1" rowspan="1">All studies</td>
<td align="left" colspan="1" rowspan="1">26(3712/6024)</td>
<td align="left" colspan="1" rowspan="1">1.47[1.21,1.79]</td>
<td align="left" colspan="1" rowspan="1">&lt;0.001</td>
<td align="left" colspan="1" rowspan="1">R</td>
<td align="left" colspan="1" rowspan="1">77.4%</td>
<td align="left" colspan="1" rowspan="1">&lt;0.001</td>
<td align="left" colspan="1" rowspan="1">0.367</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="8" rowspan="1">subgroup analyses by geographical location</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Southeast regions in mainland China</td>
<td align="left" colspan="1" rowspan="1">18(2209/3938)</td>
<td align="left" colspan="1" rowspan="1">1.69[1.38,2.07]</td>
<td align="left" colspan="1" rowspan="1">&lt;0.001</td>
<td align="left" colspan="1" rowspan="1">R</td>
<td align="left" colspan="1" rowspan="1">67.0%</td>
<td align="left" colspan="1" rowspan="1">&lt;0.001</td>
<td align="left" colspan="1" rowspan="1">0.805</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Central regions in mainland China</td>
<td align="left" colspan="1" rowspan="1">2(149/239)</td>
<td align="left" colspan="1" rowspan="1">2.55[1.64,3.97]</td>
<td align="left" colspan="1" rowspan="1">&lt;0.001</td>
<td align="left" colspan="1" rowspan="1">F</td>
<td align="left" colspan="1" rowspan="1">0.0%</td>
<td align="left" colspan="1" rowspan="1">0.680</td>
<td align="left" colspan="1" rowspan="1">
<email xlink:type="simple">@</email>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Taiwan province</td>
<td align="left" colspan="1" rowspan="1">5(878/1366)</td>
<td align="left" colspan="1" rowspan="1">0.78[0.60,1.01]</td>
<td align="left" colspan="1" rowspan="1">0.06</td>
<td align="left" colspan="1" rowspan="1">F</td>
<td align="left" colspan="1" rowspan="1">38.1%</td>
<td align="left" colspan="1" rowspan="1">0.164</td>
<td align="left" colspan="1" rowspan="1">0.555</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="8" rowspan="1">subgroup analyses by number of case</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">&lt;100</td>
<td align="left" colspan="1" rowspan="1">12(775/1546)</td>
<td align="left" colspan="1" rowspan="1">1.59[1.33,1.90]</td>
<td align="left" colspan="1" rowspan="1">&lt;0.001</td>
<td align="left" colspan="1" rowspan="1">R</td>
<td align="left" colspan="1" rowspan="1">77.8%</td>
<td align="left" colspan="1" rowspan="1">&lt;0.001</td>
<td align="left" colspan="1" rowspan="1">0.031</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">≥100</td>
<td align="left" colspan="1" rowspan="1">14(2937/4478)</td>
<td align="left" colspan="1" rowspan="1">1.36[1.23,1.50]</td>
<td align="left" colspan="1" rowspan="1">&lt;0.001</td>
<td align="left" colspan="1" rowspan="1">R</td>
<td align="left" colspan="1" rowspan="1">78.4%</td>
<td align="left" colspan="1" rowspan="1">&lt;0.001</td>
<td align="left" colspan="1" rowspan="1">0.859</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="8" rowspan="1">subgroup analyses by source of control</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">population-based</td>
<td align="left" colspan="1" rowspan="1">21(3133/4261)</td>
<td align="left" colspan="1" rowspan="1">1.47[1.17,1.84]</td>
<td align="left" colspan="1" rowspan="1">&lt;0.001</td>
<td align="left" colspan="1" rowspan="1">R</td>
<td align="left" colspan="1" rowspan="1">79.4%</td>
<td align="left" colspan="1" rowspan="1">&lt;0.001</td>
<td align="left" colspan="1" rowspan="1">0.238</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">hospital-based</td>
<td align="left" colspan="1" rowspan="1">4(533/1675)</td>
<td align="left" colspan="1" rowspan="1">1.62[1.11,2.37]</td>
<td align="left" colspan="1" rowspan="1">0.012</td>
<td align="left" colspan="1" rowspan="1">R</td>
<td align="left" colspan="1" rowspan="1">69.1%</td>
<td align="left" colspan="1" rowspan="1">0.021</td>
<td align="left" colspan="1" rowspan="1">0.472</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="nt106">
<label/>
<p>M: model of meta-analysis; R: random-effects model; F: fixed-effects model. <italic>P<sub>H</sub></italic>: <italic>P</italic> value of heterogeneity test. <italic>P<sub>E</sub></italic>: <italic>P</italic> value of Egger’s test. <italic>P<sub>OR</sub></italic>: <italic>P</italic>&lt;0.001 replace <italic>P</italic> = 0.000 and <italic>P</italic> less than 0.001. @: <italic>P</italic> values could not be calculated.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="pone-0057043-t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0057043.t003</object-id>
<label>Table 3</label>
<caption>
<title>Subgroup analysis of the association between <italic>GSTT1</italic> null genotype and HCC risk.</title>
</caption>
<alternatives>
<graphic id="pone-0057043-t003-3" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0057043.t003" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
</colgroup>
<thead>
<tr>
<td align="left" colspan="1" rowspan="1">Polymorphism</td>
<td align="left" colspan="1" rowspan="1">Null <italic>vs.</italic> Present</td>
<td align="left" colspan="1" rowspan="1">No. of studies (cases/controls)</td>
<td align="left" colspan="2" rowspan="1">Odds ratio</td>
<td align="left" colspan="1" rowspan="1">M</td>
<td align="left" colspan="2" rowspan="1">Heterogeneity</td>
<td align="left" colspan="1" rowspan="1">
<italic>P<sub>E</sub></italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">OR [95% CI]</td>
<td align="left" colspan="1" rowspan="1">
<italic>POR</italic>
</td>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">I<sup>2</sup> (%)</td>
<td align="left" colspan="1" rowspan="1">
<italic>PH</italic>
</td>
<td align="left" colspan="1" rowspan="1"/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>GSTT1</italic>
</td>
<td align="left" colspan="1" rowspan="1">All studies</td>
<td align="left" colspan="1" rowspan="1">21(3378/5400)</td>
<td align="left" colspan="1" rowspan="1">1.38[1.14,1.65]</td>
<td align="left" colspan="1" rowspan="1">&lt;0.001</td>
<td align="left" colspan="1" rowspan="1">R</td>
<td align="left" colspan="1" rowspan="1">71.1%</td>
<td align="left" colspan="1" rowspan="1">&lt;0.001</td>
<td align="left" colspan="1" rowspan="1">0.795</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="8" rowspan="1">subgroup analyses by geographical location</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Southeast regions in mainland China</td>
<td align="left" colspan="1" rowspan="1">16(2454/4019)</td>
<td align="left" colspan="1" rowspan="1">1.51[1.35,1.69]</td>
<td align="left" colspan="1" rowspan="1">&lt;0.001</td>
<td align="left" colspan="1" rowspan="1">R</td>
<td align="left" colspan="1" rowspan="1">67.1%</td>
<td align="left" colspan="1" rowspan="1">&lt;0.001</td>
<td align="left" colspan="1" rowspan="1">0.952</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Central regions in mainland China</td>
<td align="left" colspan="1" rowspan="1">1(95/103)</td>
<td align="left" colspan="1" rowspan="1">2.02[1.15,3.56]</td>
<td align="left" colspan="1" rowspan="1">0.020</td>
<td align="left" colspan="1" rowspan="1">F</td>
<td align="left" colspan="1" rowspan="1">
<email xlink:type="simple">@</email>
</td>
<td align="left" colspan="1" rowspan="1">
<email xlink:type="simple">@</email>
</td>
<td align="left" colspan="1" rowspan="1">
<email xlink:type="simple">@</email>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Taiwan province</td>
<td align="left" colspan="1" rowspan="1">4(829/1278)</td>
<td align="left" colspan="1" rowspan="1">0.94[0.78,1.14]</td>
<td align="left" colspan="1" rowspan="1">0.546</td>
<td align="left" colspan="1" rowspan="1">F</td>
<td align="left" colspan="1" rowspan="1">24.4%</td>
<td align="left" colspan="1" rowspan="1">0.265</td>
<td align="left" colspan="1" rowspan="1">0.315</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="8" rowspan="1">subgroup analyses by number of case</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">&lt;100</td>
<td align="left" colspan="1" rowspan="1">8(561/1022)</td>
<td align="left" colspan="1" rowspan="1">1.34[0.78,2.28]</td>
<td align="left" colspan="1" rowspan="1">0.258</td>
<td align="left" colspan="1" rowspan="1">R</td>
<td align="left" colspan="1" rowspan="1">81.8%</td>
<td align="left" colspan="1" rowspan="1">&lt;0.001</td>
<td align="left" colspan="1" rowspan="1">0.961</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">≥100</td>
<td align="left" colspan="1" rowspan="1">13(2817/4378)</td>
<td align="left" colspan="1" rowspan="1">1.38[1.16,1.64]</td>
<td align="left" colspan="1" rowspan="1">0.002</td>
<td align="left" colspan="1" rowspan="1">R</td>
<td align="left" colspan="1" rowspan="1">61.0%</td>
<td align="left" colspan="1" rowspan="1">&lt;0.001</td>
<td align="left" colspan="1" rowspan="1">0.560</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="8" rowspan="1">subgroup analyses by source of control</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">population-based</td>
<td align="left" colspan="1" rowspan="1">17(2845/3725)</td>
<td align="left" colspan="1" rowspan="1">1.32[1.06,1.64]</td>
<td align="left" colspan="1" rowspan="1">&lt;0.001</td>
<td align="left" colspan="1" rowspan="1">R</td>
<td align="left" colspan="1" rowspan="1">72.1%</td>
<td align="left" colspan="1" rowspan="1">&lt;0.001</td>
<td align="left" colspan="1" rowspan="1">0.746</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">hospital-based</td>
<td align="left" colspan="1" rowspan="1">4(533/1675)</td>
<td align="left" colspan="1" rowspan="1">1.60[1.14,2.26]</td>
<td align="left" colspan="1" rowspan="1">0.007</td>
<td align="left" colspan="1" rowspan="1">R</td>
<td align="left" colspan="1" rowspan="1">63.6%</td>
<td align="left" colspan="1" rowspan="1">0.041</td>
<td align="left" colspan="1" rowspan="1">0.929</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="nt107">
<label/>
<p>M: model of meta-analysis; R: random-effects model; F: fixed-effects model. <italic>P<sub>H</sub>: P</italic> value of heterogeneity test. <italic>P<sub>E</sub></italic>: <italic>P v</italic>alue of Egger’s test. <italic>P<sub>OR</sub></italic>: <italic>P</italic>&lt;0.001 replace the <italic>P</italic> = 0.000 and the <italic>P</italic> less than 0.001. @: <italic>P</italic> values could not be calculated.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="pone-0057043-t004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0057043.t004</object-id>
<label>Table 4</label>
<caption>
<title>Subgroup analysis of the association between <italic>GSTM1-GSTT1</italic> null genotype and HCC risk.</title>
</caption>
<alternatives>
<graphic id="pone-0057043-t004-4" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0057043.t004" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
</colgroup>
<thead>
<tr>
<td align="left" colspan="1" rowspan="1">Polymorphism</td>
<td align="left" colspan="1" rowspan="1">Null vs. Present</td>
<td align="left" colspan="2" rowspan="1">No. of studies (cases/controls)</td>
<td align="left" colspan="3" rowspan="1">Odds ratio</td>
<td align="left" colspan="1" rowspan="1">M</td>
<td align="left" colspan="2" rowspan="1">Heterogeneity</td>
<td align="left" colspan="1" rowspan="1">
<italic>P<sub>E</sub></italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="2" rowspan="1"/>
<td align="left" colspan="2" rowspan="1">OR [95% CI]</td>
<td align="left" colspan="1" rowspan="1">
<italic>POR</italic>
</td>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">I<sup>2</sup> (%)</td>
<td align="left" colspan="1" rowspan="1">
<italic>PH</italic>
</td>
<td align="left" colspan="1" rowspan="1"/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>GSTM1-GSTT1</italic>
</td>
<td align="left" colspan="1" rowspan="1">All studies</td>
<td align="left" colspan="2" rowspan="1">12(1763/2537)</td>
<td align="left" colspan="2" rowspan="1">1.78[1.26,2.52]</td>
<td align="left" colspan="1" rowspan="1">&lt;0.001</td>
<td align="left" colspan="1" rowspan="1">R</td>
<td align="left" colspan="1" rowspan="1">77.7%</td>
<td align="left" colspan="1" rowspan="1">&lt;0.001</td>
<td align="left" colspan="1" rowspan="1">0.535</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="10" rowspan="1">subgroup analyses by geographical location</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Southeast regions in mainland China</td>
<td align="left" colspan="2" rowspan="1">9(989/1659)</td>
<td align="left" colspan="1" rowspan="1">1.98[1.32,2.95]</td>
<td align="left" colspan="2" rowspan="1">&lt;0.001</td>
<td align="left" colspan="1" rowspan="1">R</td>
<td align="left" colspan="1" rowspan="1">70.3%</td>
<td align="left" colspan="1" rowspan="1">&lt;0.001</td>
<td align="left" colspan="1" rowspan="1">0.497</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Central regions in mainland China</td>
<td align="left" colspan="2" rowspan="1">1(95/103)</td>
<td align="left" colspan="1" rowspan="1">2.72[1.45,5.11]</td>
<td align="left" colspan="2" rowspan="1">0.002</td>
<td align="left" colspan="1" rowspan="1">F</td>
<td align="left" colspan="1" rowspan="1">
<email xlink:type="simple">@</email>
</td>
<td align="left" colspan="1" rowspan="1">
<email xlink:type="simple">@</email>
</td>
<td align="left" colspan="1" rowspan="1">
<email xlink:type="simple">@</email>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Taiwan province</td>
<td align="left" colspan="2" rowspan="1">2(679/775)</td>
<td align="left" colspan="1" rowspan="1">1.04[0.81,1.32]</td>
<td align="left" colspan="2" rowspan="1">0.770</td>
<td align="left" colspan="1" rowspan="1">F</td>
<td align="left" colspan="1" rowspan="1">0.0%</td>
<td align="left" colspan="1" rowspan="1">0.536</td>
<td align="left" colspan="1" rowspan="1">
<email xlink:type="simple">@</email>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="10" rowspan="1">subgroup analyses by number of case</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="2" rowspan="1">&lt;100</td>
<td align="left" colspan="1" rowspan="1">4(298/393)</td>
<td align="left" colspan="1" rowspan="1">1.73[0.70,4.28]</td>
<td align="left" colspan="2" rowspan="1">0.235</td>
<td align="left" colspan="1" rowspan="1">R</td>
<td align="left" colspan="1" rowspan="1">75.9%</td>
<td align="left" colspan="1" rowspan="1">0.001</td>
<td align="left" colspan="1" rowspan="1">0.115</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="2" rowspan="1">≥100</td>
<td align="left" colspan="1" rowspan="1">8(1465/2144)</td>
<td align="left" colspan="1" rowspan="1">1.70[1.17,2.48]</td>
<td align="left" colspan="2" rowspan="1">0.006</td>
<td align="left" colspan="1" rowspan="1">R</td>
<td align="left" colspan="1" rowspan="1">78.8%</td>
<td align="left" colspan="1" rowspan="1">0.001</td>
<td align="left" colspan="1" rowspan="1">0.263</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="10" rowspan="1">subgroup analyses by source of control</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="2" rowspan="1">population-based</td>
<td align="left" colspan="1" rowspan="1">9(1411/1503)</td>
<td align="left" colspan="1" rowspan="1">1.75[1.09,2.80]</td>
<td align="left" colspan="2" rowspan="1">0.020</td>
<td align="left" colspan="1" rowspan="1">R</td>
<td align="left" colspan="1" rowspan="1">81.0%</td>
<td align="left" colspan="1" rowspan="1">0.001</td>
<td align="left" colspan="1" rowspan="1">0.531</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="2" rowspan="1">hospital-based</td>
<td align="left" colspan="1" rowspan="1">3(352/1034)</td>
<td align="left" colspan="1" rowspan="1">1.86[1.16,2.97]</td>
<td align="left" colspan="2" rowspan="1">0.010</td>
<td align="left" colspan="1" rowspan="1">R</td>
<td align="left" colspan="1" rowspan="1">63.8%</td>
<td align="left" colspan="1" rowspan="1">0.063</td>
<td align="left" colspan="1" rowspan="1">0.856</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="nt108">
<label/>
<p>M: model of meta-analysis; R: random-effects model; F: fixed-effects model. <italic>P<sub>H</sub></italic>: <italic>P</italic> value of heterogeneity test. <italic>P<sub>E</sub></italic>: <italic>P</italic> value of Egger’s test. <italic>P<sub>OR</sub></italic>: <italic>P</italic>&lt;0.001 replace the <italic>P</italic> = 0.000 and the <italic>P</italic> less than 0.001. @: <italic>P</italic> values could not be calculated.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3d">
<title>4. Sensitivity and Heterogeneity Analysis</title>
<p>Sensitivity analysis was performed by sequential excluding one article each time. The significance of all ORs was not changed. We used Galbraith plot to omit some possible major sources of heterogeneous articles. The results were showed in <xref ref-type="fig" rid="pone-0057043-g005">Figure 5</xref>. In <xref ref-type="fig" rid="pone-0057043-g005">Figure 5A</xref>, we found more than 6 articles (No. 3, 6, 11, 13, 14, and 21) spotted by Galbraith plot. However, it might cause some biases by excluding those articles as the sources of heterogeneity. So we didn’t reduce the obvious between-study heterogeneity in the analyses on the <italic>GSTM1</italic> polymorphisms. In <xref ref-type="fig" rid="pone-0057043-g005">Figure 5B</xref>, <xref ref-type="fig" rid="pone-0057043-g003">3</xref> articles (No. 4, 5 and 13) were obviously spotted as the outliers and the possible sources of heterogeneity in the analysis pooled of total available studies, but another 3 articles (No. 8, 9 and 15) the outliers were not reduced because it could cause some biases. After adjustment, the association between <italic>GSTT1</italic> polymorphisms and HCC risk was increased (OR = 1.45, 95% CI: 1.24 to 1.69, <italic>P</italic>&lt;0.001, random-effects model). Galbraith plots (<xref ref-type="fig" rid="pone-0057043-g005">Figure 5C</xref>) spotted 5 articles (No. 3, 5, 8, 9 and 10) as the possible sources of heterogeneity, but only 3 articles (No. 3, 5 and 9) were omitted for the obvious between-study heterogeneity in the analyses on the <italic>GSTM1-GSTT1</italic> polymorphisms. The adjusted OR and 95% CI between <italic>GSTM1</italic>/<italic>GSTM1-GSTT1</italic> polymorphisms and HCC risk was significantly increased although heterogeneity (I<sup>2</sup><italic><sub>GSTT1</sub></italic> = 56.1%, <italic>P<sub>GSTT1</sub></italic> = 0.002; I<sup>2</sup><italic><sub>GSTM1-GSTT1</sub></italic> = 59.0%, <italic>P<sub>GSTM1-GSTT1</sub></italic> = 0.012) still existed. These results were shown in <xref ref-type="table" rid="pone-0057043-t005">Table 5</xref> and <xref ref-type="table" rid="pone-0057043-t006">Table 6</xref>.</p>
<fig id="pone-0057043-g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0057043.g005</object-id>
<label>Figure 5</label>
<caption>
<title>Galbraith plot of association between <italic>GST</italic> polymorphisms and HCC risk.</title>
<p>Each figure represents a unique article in this meta-analysis. The figures outside the three lines are spotted as the outliers and the possible sources of heterogeneity in the analysis pooled of total available studies. (A) Galbraith plot identifies the outliers from 26 studies about <italic>GSTM1</italic> polymorphisms and HCC risk. (B) Galbraith plot identifies the outliers from 21 studies about <italic>GSTT1</italic> polymorphisms and HCC risk. (C) Galbraith plot identifies the outliers from 12 studies about <italic>GSTM1-GSTT1</italic> polymorphisms and HCC risk.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0057043.g005" xlink:type="simple"/>
</fig>
<table-wrap id="pone-0057043-t005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0057043.t005</object-id>
<label>Table 5</label>
<caption>
<title>Subgroup analysis of <xref ref-type="table-fn" rid="nt110">$</xref>the adjusted association between <italic>GSTT1</italic> null genotype and HCC risk.</title>
</caption>
<alternatives>
<graphic id="pone-0057043-t005-5" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0057043.t005" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
</colgroup>
<thead>
<tr>
<td align="left" colspan="1" rowspan="1">Polymorphism</td>
<td align="left" colspan="1" rowspan="1">Null <italic>VS.</italic> Present</td>
<td align="left" colspan="1" rowspan="1">No. of studies(cases/controls)</td>
<td align="left" colspan="2" rowspan="1">Odds ratio</td>
<td align="left" colspan="1" rowspan="1">M</td>
<td align="left" colspan="2" rowspan="1">Heterogeneity</td>
<td align="left" colspan="1" rowspan="1">
<italic>P<sub>E</sub></italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">OR [95% CI]</td>
<td align="left" colspan="1" rowspan="1">
<italic>POR</italic>
</td>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">I<sup>2</sup> (%)</td>
<td align="left" colspan="1" rowspan="1">
<italic>PH</italic>
</td>
<td align="left" colspan="1" rowspan="1"/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>GSTT1</italic>
</td>
<td align="left" colspan="1" rowspan="1">All studies</td>
<td align="left" colspan="1" rowspan="1">18(3186/5111)</td>
<td align="left" colspan="1" rowspan="1">1.45[1.24,1.69]</td>
<td align="left" colspan="1" rowspan="1">&lt;0.001</td>
<td align="left" colspan="1" rowspan="1">R</td>
<td align="left" colspan="1" rowspan="1">56.1%</td>
<td align="left" colspan="1" rowspan="1">0.002</td>
<td align="left" colspan="1" rowspan="1">0.142</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="nt109">
<label/>
<p>M: model of meta-analysis; R: random-effects model; F: fixed-effects model. <italic>P<sub>H</sub></italic>: <italic>P</italic> value of heterogeneity test. <italic>P<sub>E</sub></italic>: <italic>P</italic> value of Egger’ test. <italic>P<sub>OR</sub></italic>: <italic>P</italic>&lt;0.001 replace the <italic>P</italic> = 0.000 and the <italic>P</italic> less than 0.001.</p>
</fn>
<fn id="nt110">
<label>$</label>
<p>adjusted association (after omitting 3 articles <xref ref-type="bibr" rid="pone.0057043-Bian2">[30]</xref>, <xref ref-type="bibr" rid="pone.0057043-Sun1">[34]</xref>, <xref ref-type="bibr" rid="pone.0057043-Ma2">[42]</xref>).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="pone-0057043-t006" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0057043.t006</object-id>
<label>Table 6</label>
<caption>
<title>Subgroup analysis of <sup>$</sup>the adjusted association between <italic>GSTM1-GSTT1</italic> null genotype and HCC risk.</title>
</caption>
<alternatives>
<graphic id="pone-0057043-t006-6" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0057043.t006" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
</colgroup>
<thead>
<tr>
<td align="left" colspan="1" rowspan="1">Polymorphism</td>
<td align="left" colspan="1" rowspan="1">Null <italic>vs.</italic> Present</td>
<td align="left" colspan="1" rowspan="1">No. of studies (cases/controls)</td>
<td align="left" colspan="2" rowspan="1">Odds ratio</td>
<td align="left" colspan="1" rowspan="1">M</td>
<td align="left" colspan="2" rowspan="1">Heterogeneity</td>
<td align="left" colspan="1" rowspan="1">
<italic>P<sub>E</sub></italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">OR [95% CI]</td>
<td align="left" colspan="1" rowspan="1">
<italic>POR</italic>
</td>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">I<sup>2</sup> (%)</td>
<td align="left" colspan="1" rowspan="1">
<italic>PH</italic>
</td>
<td align="left" colspan="1" rowspan="1"/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>GSTM1-GSTT1</italic>
</td>
<td align="left" colspan="1" rowspan="1">All studies</td>
<td align="left" colspan="1" rowspan="1">9(942/1674)</td>
<td align="left" colspan="1" rowspan="1">1.98[1.43, 2.74]</td>
<td align="left" colspan="1" rowspan="1">&lt;0.001</td>
<td align="left" colspan="1" rowspan="1">R</td>
<td align="left" colspan="1" rowspan="1">59.0%</td>
<td align="left" colspan="1" rowspan="1">0.012</td>
<td align="left" colspan="1" rowspan="1">0.236</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="nt111">
<label/>
<p>M: model of meta-analysis; R: random-effects model; F: fixed-effects model. <italic>P<sub>H</sub></italic>: <italic>P</italic> value of heterogeneity test. <italic>P<sub>E</sub></italic>: <italic>P</italic> value of Egger’s test. <italic>P<sub>OR</sub></italic>: <italic>P</italic>&lt;0.001 replace the <italic>P</italic> = 0.000 and the <italic>P</italic> less than 0.001. <sup>$</sup>: adjusted association (after omitting 3 articles <xref ref-type="bibr" rid="pone.0057043-Bian2">[30]</xref>, <xref ref-type="bibr" rid="pone.0057043-Yu3">[37]</xref>, <xref ref-type="bibr" rid="pone.0057043-Deng1">[44]</xref>).</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3e">
<title>5. Potential Publication Bias</title>
<p>Beggar’s funnel plots and Egger’s publication bias plots were used to assess the potential publication bias for <italic>GSTM1</italic>, <italic>GSTT1</italic>, and dual-null genotype of <italic>GSTM1-GSTT1</italic> (<xref ref-type="fig" rid="pone-0057043-g006">Figure 6</xref>). No publication bias was detected by Egger’s test (<italic>P<sub>E</sub></italic> = 0.367 for <italic>GSTM1</italic>, <italic>P<sub>E</sub></italic> = 0.795 for <italic>GSTT1</italic> and <italic>P<sub>E</sub></italic> = 0.64 for dual-null genotype of <italic>GSTM1-GSTT1</italic>).</p>
<fig id="pone-0057043-g006" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0057043.g006</object-id>
<label>Figure 6</label>
<caption>
<title>Beggar’s test and Egger’s test of <italic>GST</italic> polymorphisms and HCC risk.</title>
<p>Beggar’s funnel plot is used to detect potential publication bias in which a symmetric funnel shape means no publication bias. Egger’s linear regression test is used to quantify the potential presence of publication bias. Both Beggar’s test and Egger’s test show that no publication bias has been found from 26 inclusive studies about the association between <italic>GSTM1</italic> polymorphisms and HCC risk (A and B), 21 inclusive studies about the association between <italic>GSTT1</italic> polymorphisms and HCC risk (C and D), and 12 inclusive studies about the association between dual-null genotype of <italic>GSTM1-GSTT1</italic> and HCC risk polymorphisms and HCC risk (E and F).</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0057043.g006" xlink:type="simple"/>
</fig>
</sec>
</sec>
<sec id="s4">
<title>Discussion</title>
<p>The association between <italic>GST</italic> genetic polymorphisms and HCC risk are inconsistent according to the present research results. This may be caused by several reasons. Improper matching or insufficient case and control numbers used in the studies are all possible reasons. One meta-analysis <xref ref-type="bibr" rid="pone.0057043-Yu1">[10]</xref> published in 2009 with the association between <italic>GST</italic> genetic polymorphisms and HCC risk didn’t cover all conclusive articles published in Chinese and English databases. In this meta-analysis paper, overlapped data was found in two adopted studies <xref ref-type="bibr" rid="pone.0057043-Yu3">[37]</xref>, <xref ref-type="bibr" rid="pone.0057043-Chen2">[51]</xref> (two different articles with different case and control numbers written by the same research group). Another two adopted studies <xref ref-type="bibr" rid="pone.0057043-Zhang1">[52]</xref>, <xref ref-type="bibr" rid="pone.0057043-Zhu2">[53]</xref> in this meta-analysis didn’t match properly for the cases (HBV carried) and controls (HBV negative). The other meta-analysis <xref ref-type="bibr" rid="pone.0057043-Chen1">[11]</xref> published in 2012 about Asian population included a study <xref ref-type="bibr" rid="pone.0057043-McGlynn2">[<sup>38</sup>]</xref> with unclear case and control numbers. In addition, some more studies <xref ref-type="bibr" rid="pone.0057043-Kao1">[47]</xref>–<xref ref-type="bibr" rid="pone.0057043-Li2">[50]</xref> related with the association between <italic>GST</italic> genetic polymorphisms and HCC risk have emerged since these two meta-analysis papers were published.</p>
<p>To evaluate the association of <italic>GST</italic> genetic polymorphisms and susceptibility to HCC in the Chinese population, we performed an updated systematic meta-analysis. In this study, 27 articles (3781 patients and 6104 controls) were selected from Chinese and English databases. 26 studies (3712 cases and 6024 controls) out of the 27 articles were used for investigation of the relationship between <italic>GSTM1</italic> null genotype and HCC susceptibility. 21 studies (3378 cases and 5400 controls) out of the 27 articles were used to evaluate the relationship between <italic>GSTT1</italic> null genotype and HCC susceptibility. 12 studies (1763 cases and 2537 controls) were applied for evaluation for the <italic>GSTM1-GSTT1</italic> gene. Random-effects model of meta-analysis shows significant associations of polymorphisms of <italic>GSTM1</italic> null gene (OR = 1.47, 95% CI: 1.21 to 1.79, <italic>P</italic>&lt;0.001), <italic>GSTT1</italic> null gene (OR = 1.38, 95% CI: 1.14 to 1.65, <italic>P</italic>&lt;0.001), and <italic>GSTM1-GSTT1</italic> dual null gene (OR = 1.79, 95% CI: 1.26 to 2.53, <italic>P</italic>&lt;0.001), respectively, with HCC risk in the Chinese population. Subgroup analyses on <italic>GSTM1</italic> null gene indicate that geographical location (China mainland, but not in Taiwan region), case numbers and source of controls are significantly associated with HCC risk. Results of subgroup analyses on <italic>GSTT1</italic> null gene and <italic>GSTM1-GSTT1</italic> dual null gene indicate that geographical location (China mainland, but not in Taiwan region), case numbers (≥100, but not &lt;100) and source of controls are also significantly associated with HCC risk. Reasons for inconsistent in conclusions between China mainland and Taiwan region may be caused by environmental factors. Moreover, limited investigative numbers of the case-control/followed up studies from Taiwan region may result in difficulty for getting stable risk estimation, though these investigations own low between-study heterogeneity. In addition, studies with case number less than 100 may have effects on drawing a proper estimation for the association between <italic>GST</italic> genetic polymorphisms and HCC risk. Therefore, further well design case-control/followed-up studies, especially with a larger case number, are necessary to provide better evidences for the evaluation. Heterogeneity analysis is a key part of meta-analysis. Q statistic test (Cochran’s Q statistic) and I<sup>2</sup> statistic test are commonly used to test and quantify the between-study heterogeneity. The major source of heterogeneity in the China mainland population detected in the subgroup analysis might come from the environmental difference which could affect their sensitivity to particular genomic variants. In this meta-analysis, Galbraith plot was performed for identifying the articles with possible heterogeneity. However, in the analyses on the <italic>GSTM1</italic> polymorphism and HCC risk, we kept several articles with obvious between-study heterogeneity because too many articles omitting could cause some biases. For the association of <italic>GSTT1</italic> null gene and HCC risk, we deleted 3 articles <xref ref-type="bibr" rid="pone.0057043-Bian2">[30]</xref>, <xref ref-type="bibr" rid="pone.0057043-Sun1">[34]</xref>, <xref ref-type="bibr" rid="pone.0057043-Ma2">[42]</xref> which were obviously spotted as the outliers with major source of between-heterogeneity, and same procedures were done for <italic>GSTM1-GSTT1</italic> gene (3 article deletion <xref ref-type="bibr" rid="pone.0057043-Bian2">[30]</xref>, <xref ref-type="bibr" rid="pone.0057043-Yu3">[37]</xref>, <xref ref-type="bibr" rid="pone.0057043-Deng1">[44]</xref>). Regretfully, the between-heterogeneity didn’t decrease significantly even if the adjustment was done in both <italic>GSTT1</italic> and <italic>GSTM1-GSTT1</italic> genetic polymorphisms (I<sup>2</sup><italic><sub>GSTT1</sub></italic> = 56.1%, <italic>P<sub>GSTT1</sub></italic> = 0.002; I<sup>2</sup><italic><sub>GSTM1-GSTT1</sub></italic> = 59.0%, <italic>P<sub>GSTM1-GSTT1</sub></italic> = 0.012). Therefore, we applied the random-effects model to evaluate the pooled OR for <italic>GSTT1</italic> and <italic>GSTM1-GSTT1</italic> genes, respectively. After the above adjustments, the associations were increased between <italic>GSTT1</italic> and <italic>GSTM1-GSTT1</italic> polymorphisms and HCC risk (OR<italic><sub>GSTT1</sub></italic> = 1.45, 95% CI: 1.24 to 1.69; OR<italic><sub>GSTM1-GSTT1</sub></italic> = 1.98, 95% CI: 1.43 to 2.74). In this study, Beggar’s funnel plots and Egger’s linear regression test were applied to assess the potential publication bias. No publication bias was detected (<italic>P<sub>E</sub></italic> = 0.367 for <italic>GSTM1</italic>, <italic>P<sub>E</sub></italic> = 0.795 for <italic>GSTT1</italic> and <italic>P<sub>E</sub></italic> = 0.64 for dual-null genotype of <italic>GSTM1-GSTT1,</italic> Egger’s linear regression test).</p>
<p>Research evidences suggest that <italic>GST</italic> genetic polymorphisms are associated with the susceptibility to several carcinomas. Takahiko Katoh <italic>et al.</italic> <xref ref-type="bibr" rid="pone.0057043-Katoh1">[54]</xref> showed the <italic>GSTM1</italic> null genotype might be associated with susceptibility to gastric adenocarcinoma and distal colorectal adenocarcinoma in Japanese population. Wang J <italic>et al</italic>. <xref ref-type="bibr" rid="pone.0057043-Wang2">[55]</xref> found that the combination of <italic>GSTM1</italic> null and <italic>GSTP1</italic> Val was significantly associated with an elevated lung adenocarcinoma risk (OR = 2.4, 95% CI: 1.1 to 5.1). Helzlsouer K J <italic>et al</italic>. <xref ref-type="bibr" rid="pone.0057043-Helzlsouer1">[56]</xref> considered that genetic variability in members of the <italic>GST</italic> gene family might be associated with an increased susceptibility to breast cancer (OR = 3.77, 95% CI: 1.10 to 12.88). Compared to the control group value of 41.8%, Zhong S <italic>et al</italic>. <xref ref-type="bibr" rid="pone.0057043-Zhong1">[57]</xref> found a significant excess of 56.1% <italic>GSTM1</italic> gene null individuals in colorectal cancer group. Our meta-analysis results demonstrate that there is an association between <italic>GST</italic> genetic polymorphisms and susceptibility to HCC in the Chinese population. Thus, further epidemiological and molecular biological studies are necessary to clarify the role of <italic>GST</italic> genetic polymorphisms in HCC and other carcinomas.</p>
<p>Nevertheless, there were several limitations to this meta-analysis. (1) Observational studies were susceptible to various biases such as selection bias. Due to some studies without clear explanation for the pathologic diagnostic results of all/part subjects (<xref ref-type="table" rid="pone-0057043-t001">Table 1</xref>), therefore, some selection bias might be unavoidable. (2) In some studies, participants in control groups stemmed from hospital-based population might not fully represent the population-based controls, which could distort the results (<xref ref-type="table" rid="pone-0057043-t001">Table 1</xref>). (3) The conclusions draw from subgroup analysis might be limited due to a low statistic power from the small sample size. (4) Each study had its own inclusive criteria. For example, some studies selected from HbsAg positive population, while others selected the common people or healthy population. Due to these reasons, some bias might bring influence on the results. (5) Not only genetic polymorphisms but other factors such as alcohol consumption, AFB1 status, and chronic infection of HBV/HCV might also play vital roles in the development of HCC. Owning to the lack of sufficient data, gene-environment interactive functions were not evaluated in this meta-analysis, which might also have an influence on the precision of the conclusion.</p>
<p>In summary, our results suggest <italic>GST</italic> genetic polymorphisms are associated with the increased risk of HCC in the Chinese population. To further evaluate gene-to-gene and gene-to-environment combined effects on <italic>GST</italic> genetic polymorphisms and HCC,both large scale multicenter epidemiological studies in total population and/or selected population with different environmental background are urgently needed.</p>
</sec>
</body>
<back>
<ack>
<p>The excellent assistance of Linda Bowman, Dechuan Kong and Jian Chen in the preparation of this article is greatly appreciated. This work was partly supported by K.C. Wong Magna Fund in Ningbo University.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0057043-Cabibbo1">
<label>1</label>
<mixed-citation publication-type="other" xlink:type="simple">Cabibbo G, Maida M, Genco C, Antonucci M, Cammà C (2012) Causes of and Prevention Strategies for Hepatocellular Carcinoma; 2012. Elsevier. pp. 374–383.</mixed-citation>
</ref>
<ref id="pone.0057043-Aghemo1">
<label>2</label>
<mixed-citation publication-type="other" xlink:type="simple">Aghemo A, Colombo M (2012) Hepatocellular carcinoma in chronic hepatitis C: from bench to bedside; Springer. pp. 1–10.</mixed-citation>
</ref>
<ref id="pone.0057043-French1">
<label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>French</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhong</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Morgan</surname><given-names>TR</given-names></name>, <name name-style="western"><surname>Buslon</surname><given-names>V</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Alcoholic liver disease-Hepatocellular carcinoma transformation</article-title>. <source>Journal of Gastrointestinal Oncology</source> <volume>3</volume>: <fpage>174</fpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Jemal1">
<label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jemal</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Siegel</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ward</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Hao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Cancer statistics, 2009</article-title>. <source>CA: a cancer journal for clinicians</source> <volume>59</volume>: <fpage>225</fpage>–<lpage>249</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Jemal2">
<label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jemal</surname><given-names>A</given-names></name> (<year>2010</year>) <collab xlink:type="simple">Center MM, DeSantis C, Ward EM</collab> (<year>2010</year>) <article-title>Global patterns of cancer incidence and mortality rates and trends</article-title>. <source>Cancer Epidemiology Biomarkers &amp; Prevention</source> <volume>19</volume>: <fpage>1893</fpage>–<lpage>1907</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Annick1">
<label>6</label>
<mixed-citation publication-type="other" xlink:type="simple">Annick Buendia M. Genetics of hepatocellular carcinoma; 2000. Elsevier. 185–200.</mixed-citation>
</ref>
<ref id="pone.0057043-Thorgeirsson1">
<label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thorgeirsson</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Grisham</surname><given-names>JW</given-names></name> (<year>2002</year>) <article-title>Molecular pathogenesis of human hepatocellular carcinoma</article-title>. <source>Nature genetics</source> <volume>31</volume>: <fpage>339</fpage>–<lpage>346</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Farazi1">
<label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Farazi</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>DePinho</surname><given-names>RA</given-names></name> (<year>2006</year>) <article-title>Hepatocellular carcinoma pathogenesis: from genes to environment</article-title>. <source>Nature Reviews Cancer</source> <volume>6</volume>: <fpage>674</fpage>–<lpage>687</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Wang1">
<label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Z</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis</article-title>. <source>Journal of Hepatology</source> <volume>53</volume>: <fpage>508</fpage>–<lpage>518</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Yu1">
<label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yu</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>CY</given-names></name>, <name name-style="western"><surname>Xi</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>RQ</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>GST polymorphisms are associated with hepatocellular carcinoma risk in Chinese population</article-title>. <source>World Journal of Gastroenterology: WJG</source> <volume>17</volume>: <fpage>3248</fpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Chen1">
<label>11</label>
<mixed-citation publication-type="other" xlink:type="simple">Chen J, Ma L, Peng NF, Wang SJ, Li LQ (2012) A meta-analysis of the relationship between glutathione S-transferases gene polymorphism and hepatocellular carcinoma in Asian population. Molecular Biology Reports: 1–11.</mixed-citation>
</ref>
<ref id="pone.0057043-Beasley1">
<label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Beasley</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Hwang</surname><given-names>LY</given-names></name>, <name name-style="western"><surname>Chien</surname><given-names>CS</given-names></name> (<year>1981</year>) <article-title>Hepatocellular carcinoma and hepatitis B virus</article-title>. <source>The Lancet</source> <volume>318</volume>: <fpage>1129</fpage>–<lpage>1133</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-McGlynn1">
<label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McGlynn</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Rosvold</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Lustbader</surname><given-names>ED</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Clapper</surname><given-names>ML</given-names></name>, <etal>et al</etal>. (<year>1995</year>) <article-title>Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1</article-title>. <source>Proceedings of the National Academy of Sciences</source> <volume>92</volume>: <fpage>2384</fpage>–<lpage>2387</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Udomsinprasert1">
<label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Udomsinprasert</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Pongjaroenkit</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wongsantichon</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Oakley</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Prapanthadara</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Identification, characterization and structure of a new Delta class glutathione transferase isoenzyme</article-title>. <source>Biochemical Journal</source> <volume>388</volume>: <fpage>763</fpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Atkinson1">
<label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Atkinson</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Babbitt</surname><given-names>PC</given-names></name> (<year>2009</year>) <article-title>Glutathione transferases are structural and functional outliers in the thioredoxin fold</article-title>. <source>Biochemistry</source> <volume>48</volume>: <fpage>11108</fpage>–<lpage>11116</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Hayes1">
<label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hayes</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Flanagan</surname><given-names>JU</given-names></name>, <name name-style="western"><surname>Jowsey</surname><given-names>IR</given-names></name> (<year>2005</year>) <article-title>Glutathione transferases</article-title>. <source>Annu Rev Pharmacol Toxicol</source> <volume>45</volume>: <fpage>51</fpage>–<lpage>88</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Strange1">
<label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Strange</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Spiteri</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Ramachandran</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Fryer</surname><given-names>AA</given-names></name> (<year>2001</year>) <article-title>Glutathione-S-transferase family of enzymes</article-title>. <source>Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis</source> <volume>482</volume>: <fpage>21</fpage>–<lpage>26</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Higgins1">
<label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>SG</given-names></name> (<year>2002</year>) <article-title>Quantifying heterogeneity in a meta-analysis</article-title>. <source>Statistics in Medicine</source> <volume>21</volume>: <fpage>1539</fpage>–<lpage>1558</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-HuedoMedina1">
<label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Huedo-Medina</surname><given-names>TB</given-names></name>, <name name-style="western"><surname>Sánchez-Meca</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Marín-Martínez</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Botella</surname><given-names>J</given-names></name> (<year>2006</year>) <article-title>Assessing heterogeneity in meta-analysis: Q statistic or I<sup>2</sup> index?</article-title> <source>Psychological methods</source> <volume>11</volume>: <fpage>193</fpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Hedges1">
<label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hedges</surname><given-names>LV</given-names></name>, <name name-style="western"><surname>Vevea</surname><given-names>JL</given-names></name> (<year>1998</year>) <article-title>Fixed-and random-effects models in meta-analysis</article-title>. <source>Psychological methods</source> <volume>3</volume>: <fpage>486</fpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Begg1">
<label>21</label>
<mixed-citation publication-type="other" xlink:type="simple">Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics: 1088–1101.</mixed-citation>
</ref>
<ref id="pone.0057043-Egger1">
<label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>GD</given-names></name>, <name name-style="western"><surname>Schneider</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Minder</surname><given-names>C</given-names></name> (<year>1997</year>) <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source> <volume>315</volume>: <fpage>629</fpage>–<lpage>634</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Higgins2">
<label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Deeks</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name> (<year>2003</year>) <article-title>Measuring inconsistency in meta-analyses</article-title>. <source>BMJ</source> <volume>327</volume>: <fpage>557</fpage>–<lpage>560</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Hsieh1">
<label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hsieh</surname><given-names>LL</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Liaw</surname><given-names>YF</given-names></name> (<year>1996</year>) <article-title>L-myc, GST Ml genetic polymorphism and hepatocellular carcinoma risk among chronic hepatitis B carriers</article-title>. <source>Cancer Letters</source> <volume>103</volume>: <fpage>171</fpage>–<lpage>176</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Bian1">
<label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bian</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name> (<year>1996</year>) <article-title>Relationship between GSTM1 NULL genotype and genetic susceptibility to primary hepatocellular carcinoma</article-title>. <source>Chinese Journal of Medical Genetics</source> <volume>13</volume>: <fpage>353</fpage>–<lpage>353</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Hu1">
<label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Sheng</surname><given-names>FM</given-names></name> (<year>1997</year>) <article-title>Association between GSTM1 gene polymorphism of primary hepatocellular carcinoma and mutation of p53 codon 249</article-title>. <source>Chinese Journal of Medical Genetics</source> <volume>14</volume>: <fpage>76</fpage>–<lpage>78</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Dong1">
<label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dong</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>GC</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Fu</surname><given-names>YP</given-names></name> (<year>1997</year>) <article-title>Polymorphisms of GSTT1 and M1 Genotypes and Their Effects on Elevated Aflatoxin Exposure and Increased Risk of Hepatocellular Carcinoma</article-title>. <source>Zhong Liu Fang Zhi Yan Jiu</source> <volume>24</volume>: <fpage>327</fpage>–<lpage>329</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Dong2">
<label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dong</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>SZ</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>GC</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name> (<year>1998</year>) <article-title>Association of polymorphisms of glutathione S-transferase M1 and T1 genotypes with elevated aflatoxin and increased risk of primary liver cancer</article-title>. <source>World Chinese Journal of Digestology</source> <volume>6</volume>: <fpage>463</fpage>–<lpage>466</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Yu2">
<label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yu</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Chiu</surname><given-names>YH</given-names></name>, <name name-style="western"><surname>Chiang</surname><given-names>YC</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>TH</given-names></name>, <etal>et al</etal>. (<year>1999</year>) <article-title>Plasma carotenoids, glutathione S-transferase M1 and T1 genetic polymorphisms, and risk of hepatocellular carcinoma: Independent and interactive effects</article-title>. <source>American Journal of Epidemiology</source> <volume>149</volume>: <fpage>621</fpage>–<lpage>629</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Bian2">
<label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bian</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>FM</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>TR</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>XH</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>Susceptibility to hepatocellular carcinoma associated with null genotypes of GSTM1 and GSTT1</article-title>. <source>World Journal of Gastroenterology</source> <volume>6</volume>: <fpage>228</fpage>–<lpage>230</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Ma1">
<label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ma</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>ZL</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>YP</given-names></name> (<year>2001</year>) <article-title>Study of the deletion mutation of glutathione S transferase M1 gene and its role in susceptibility to hepatocellular carcinoma</article-title>. <source>Chinese Journal of Cancer Research</source> <volume>13</volume>: <fpage>176</fpage>–<lpage>178</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Wu1">
<label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wu</surname><given-names>HL</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>RI</given-names></name> (<year>2000</year>) <article-title>Relationship Between GSTM1 Gene Polymorphism and Genetic Susceptibility to Primary Hepatocellular Carcinoma</article-title>. <source>The Practical Journal of Cancer</source> <volume>15</volume>: <fpage>463</fpage>–<lpage>465</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Zhu1">
<label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhu</surname><given-names>WC</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Chu</surname><given-names>XW</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>M</given-names></name> (<year>2001</year>) <article-title>Relationship Study Between Gene Polymorphism of CYP1A1,GSTM1 and Genetic Susceptibility of Primary Hepatocellar Carcinoma</article-title>. <source>China J Cancer Prev Treat</source> <volume>8</volume>: <fpage>572</fpage>–<lpage>574</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Sun1">
<label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sun</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>LY</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>SN</given-names></name>, <name name-style="western"><surname>You</surname><given-names>SL</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Genetic polymorphisms of glutathione S-transferases M1 and T1 associated with susceptibility to aflatoxin-related hepatocarcinogenesis among chronic hepatitis B carriers: A nested case-control study in Taiwan</article-title>. <source>Carcinogenesis</source> <volume>22</volume>: <fpage>1289</fpage>–<lpage>1294</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Liu1">
<label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>CZ</given-names></name>, <name name-style="western"><surname>Bian</surname><given-names>JC</given-names></name> (<year>2002</year>) <article-title>Genetic Polymorphism of Glutathione S-transferase M 1,T1,P1on Susceptibility Hepatocellular Carcinoma</article-title>. <source>China Public Health</source> <volume>18</volume>: <fpage>935</fpage>–<lpage>936</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Liu2">
<label>36</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>ZG</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>YP</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>ZL</surname><given-names>D</given-names></name> (<year>2003</year>) <article-title>Population with GSTT1 gene deletion and the relationship to hepatocellular carcinoma from guangxi</article-title>. <source>Journal of Guangxi Medical University</source> <volume>2</volume>: <fpage>002</fpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Yu3">
<label>37</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yu</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>IJ</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>CJ</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma</article-title>. <source>Journal of the National Cancer Institute</source> <volume>95</volume>: <fpage>1485</fpage>–<lpage>1488</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-McGlynn2">
<label>38</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McGlynn</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Hunter</surname><given-names>K</given-names></name>, <name name-style="western"><surname>LeVoyer</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Roush</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wise</surname><given-names>P</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans</article-title>. <source>Cancer Research</source> <volume>63</volume>: <fpage>4594</fpage>–<lpage>4601</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Li1">
<label>39</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>JZ</given-names></name>, <name name-style="western"><surname>Ding</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Cao</surname><given-names>HX</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Impact of Genetic Polymorphism of Glutathione S-transferase T1,M1 on the Risk of Primary Hepatocellular Carcinoma in Alcohol Drinkers</article-title>. <source>The Practical Journal of Cancer</source> <volume>19</volume>: <fpage>229</fpage>–<lpage>232</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-He1">
<label>40</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>He</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>YY</given-names></name>, <name name-style="western"><surname>Zhong</surname><given-names>WG</given-names></name>, <name name-style="western"><surname>Su</surname><given-names>SG</given-names></name> (<year>2004</year>) <article-title>Relationship between Polymorphisms of Phase II Metabolic Genes and the Susceptibility to Hepatocellular Carcinoma in Guangxi</article-title>. <source>The Practical Journal of Cancer</source> <volume>19</volume>: <fpage>460</fpage>–<lpage>462</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Guo1">
<label>41</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Guo</surname><given-names>HY</given-names></name>, <name name-style="western"><surname>Bian</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>QM</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>ZM</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>The null genotypes of GSTM1 and GSTT1 and the genetic susceptibility of primary liver cancer in Luoyang,China</article-title>. <source>Tumor Jan</source> <volume>25</volume>: <fpage>58</fpage>–<lpage>61</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Ma2">
<label>42</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ma</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>YX</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>HT</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>XM</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Glutathione-S-transferase M1 and T1 polymorphisms and susceptibility to liver cancer in hepatitis B surface antigen positive population</article-title>. <source>Medical Journal of the Chinese People’s Armed Police</source> <volume>27</volume>: <fpage>656</fpage>–<lpage>657</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Long1">
<label>43</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Long</surname><given-names>XD</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>YP</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>ZL</given-names></name> (<year>2005</year>) <article-title>Study on the detoxication gene gstM1-gstT1-null and susceptibility to aflatoxin B1 related hepatocellular carcinoma in Guangxi</article-title>. <source>Chinese Journal of Epidemiology</source> <volume>26</volume>: <fpage>777</fpage>–<lpage>781</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Deng1">
<label>44</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Deng</surname><given-names>ZL</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>YP</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>Y</given-names></name> (<year>2005</year>) <article-title>Polymorphism of glutathione S-transferase mu 1 and theta 1 genes and hepatocellular carcinoma in southern Guangxi, China</article-title>. <source>World Journal of Gastroenterology</source> <volume>11</volume>: <fpage>272</fpage>–<lpage>274</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Long2">
<label>45</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Long</surname><given-names>XD</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>YP</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>ZL</given-names></name> (<year>2006</year>) <article-title>The polymorphisms of GSTM1, GSTT1, HYL1*2, and XRCC1, and aflatoxin B1-related hepatocellular carcinoma in Guangxi population, China</article-title>. <source>Hepatology Research</source> <volume>36</volume>: <fpage>48</fpage>–<lpage>55</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Yang1">
<label>46</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname><given-names>ZG</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>YA</given-names></name>, <name name-style="western"><surname>Kuang</surname><given-names>ZP</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>XL</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>WM</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Relationship between genetic polymorphisms of glutathione-s-transferase M1,T1 genes and susceptibility to hepatocellular carcinoma in population of Fusui District of Guangxi Zhuang Autonomous Region</article-title>. <source>Chinese Journal of Cancer Prevention and Treatment</source> <volume>16</volume>: <fpage>970</fpage>–<lpage>973</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Kao1">
<label>47</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kao</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>MUK</given-names></name>, <name name-style="western"><surname>Kuo</surname><given-names>WUH</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>TY</given-names></name>, <name name-style="western"><surname>Su</surname><given-names>SC</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Influence of glutathione-S-transferase theta (GSTT1) and mu (GSTM1) gene polymorphisms on the susceptibility of hepatocellular carcinoma in Taiwan</article-title>. <source>Journal of Surgical Oncology</source> <volume>102</volume>: <fpage>301</fpage>–<lpage>307</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Wei1">
<label>48</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wei</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Long</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>Z</given-names></name> (<year>2012</year>) <article-title>Genetic polymorphism of glutathione-S-transferase M1 and T1 in associated with carcinogenesis of hepatocellular carcinoma and nasopharyngeal carcinoma</article-title>. <source>Chinese-German Journal of Clinical Oncology</source> <volume>11</volume>: <fpage>138</fpage>–<lpage>141</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Tang1">
<label>49</label>
<mixed-citation publication-type="other" xlink:type="simple">Tang YT, Li XP, Liu TQ, Yang JR, Luo JQ, <etal>et al</etal>.. (2012) A study of genetic polymorphisms of Glutathione S-transferase in patients with hepatocellular carcinoma. Chin J Lab Diagn 16.</mixed-citation>
</ref>
<ref id="pone.0057043-Li2">
<label>50</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname><given-names>CG</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>ZM</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>MG</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Predictive Role of Glutathione-S-transferase Gene Polymorphisms in Risk and Prognosis of Hepatocellular Carcinoma</article-title>. <source>Asian Pacific Journal of Cancer Prevention</source> <volume>13</volume>: <fpage>3247</fpage>–<lpage>3252</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Chen2">
<label>51</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Liaw</surname><given-names>YF</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma</article-title>. <source>International Journal of Epidemiology</source> <volume>34</volume>: <fpage>1310</fpage>–<lpage>1318</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Zhang1">
<label>52</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname><given-names>YC</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>YQ</given-names></name> (<year>2005</year>) <article-title>Study on genetic polymorphisms of xenobiotica metabolizing enzymes in hepatitis B virus- associated hepatic disease</article-title>. <source>Wenzhou Yi Xue Yuan Xue Bao</source> <volume>35</volume>: <fpage>464</fpage>–<lpage>467</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Zhu2">
<label>53</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhu</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>XH</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>LF</given-names></name> (<year>2005</year>) <article-title>Association of genetic polymorphisms in glutathione S-transferases M1 with hepatitis beta-related hepatocellular carcinoma</article-title>. <source>Journal of Zhejiang University (Medical Sciences)</source> <volume>34</volume>: <fpage>126</fpage>–<lpage>130</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Katoh1">
<label>54</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Katoh</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Nagata</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Kuroda</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Itoh</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kawahara</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>1996</year>) <article-title>Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma</article-title>. <source>Carcinogenesis</source> <volume>17</volume>: <fpage>1855</fpage>–<lpage>1859</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Wang2">
<label>55</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ding</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Tokudome</surname><given-names>S</given-names></name> (<year>2003</year>) <article-title>GST genetic polymorphisms and lung adenocarcinoma susceptibility in a Chinese population</article-title>. <source>Cancer Letters</source> <volume>201</volume>: <fpage>185</fpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Helzlsouer1">
<label>56</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Helzlsouer</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>HY</given-names></name>, <name name-style="western"><surname>Hoffman</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Alberg</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Comstock</surname><given-names>GW</given-names></name>, <etal>et al</etal>. (<year>1998</year>) <article-title>Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer</article-title>. <source>Journal of the National Cancer Institute</source> <volume>90</volume>: <fpage>512</fpage>–<lpage>518</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Zhong1">
<label>57</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhong</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wyllie</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Barnes</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Wolf</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Spurr</surname><given-names>N</given-names></name> (<year>1993</year>) <article-title>Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer</article-title>. <source>Carcinogenesis</source> <volume>14</volume>: <fpage>1821</fpage>–<lpage>1824</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Deng2">
<label>58</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Deng</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Zi</surname><given-names>XL</given-names></name> (<year>1997</year>) <article-title>Relationship between Deletion of Slutathion S-trausferase Gene and Susceptibility to Primary Hepatocellular Carcinoma</article-title>. <source>Chinese Journal of Public Health</source> <volume>16</volume>: <fpage>141</fpage>–<lpage>142</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Yu4">
<label>59</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yu</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Gladek-Yarborough</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Chiamprasert</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Santella</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Liaw</surname><given-names>YF</given-names></name>, <etal>et al</etal>. (<year>1995</year>) <article-title>Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma</article-title>. <source>Gastroenterology</source> <volume>109</volume>: <fpage>1266</fpage>–<lpage>1273</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Chen3">
<label>60</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Liaw</surname><given-names>YF</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>LW</given-names></name>, <name name-style="western"><surname>Chiamprasert</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>1996</year>) <article-title>Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma</article-title>. <source>American Journal of Human Genetics</source> <volume>59</volume>: <fpage>128</fpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Yu5">
<label>61</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yu</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Lien</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Chiu</surname><given-names>YH</given-names></name>, <name name-style="western"><surname>Santella</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Liaw</surname><given-names>YF</given-names></name>, <etal>et al</etal>. (<year>1997</year>) <article-title>Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan</article-title>. <source>Journal of Hepatology</source> <volume>27</volume>: <fpage>320</fpage>–<lpage>330</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Bian3">
<label>62</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bian</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>1999</year>) <article-title>The mutation of deletion for glutathione S-transferase M1 gene in the tissue of hepatocellular carcinoma</article-title>. <source>Chinese Journal of Medical Genetics</source> <volume>16</volume>: <fpage>171</fpage>–<lpage>173</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Sun2">
<label>63</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sun</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>C</given-names></name>, <name name-style="western"><surname>You</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Determinants of formation of aflatoxin-albumin adducts: a seven-township study in Taiwan</article-title>. <source>British Journal of Cancer</source> <volume>87</volume>: <fpage>966</fpage>–<lpage>970</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-He2">
<label>64</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>He</surname><given-names>S</given-names></name> (<year>2005</year>) <article-title>the analysis of GSTM1,GSTT1 gene polymorphism in HCC</article-title>. <source>Joural of Guangxi Medical University</source> <volume>22</volume>: <fpage>875</fpage>–<lpage>877</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-He3">
<label>65</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>He</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>YH</given-names></name>, <name name-style="western"><surname>M</surname><given-names>ZH</given-names></name> (<year>2007</year>) <article-title>Effect of interaction between smoking, alcohol drinking and polymorphisms of phase II metabolic genes on the susceptibility of hepatocellular carcinoma</article-title>. <source>Basic Medical Sciences and Clinics</source> <volume>27</volume>: <fpage>666</fpage>–<lpage>669</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-He4">
<label>66</label>
<mixed-citation publication-type="other" xlink:type="simple">He SJ, Gu YH, M ZH (2008) The association between GSTM1 gene polymorphism and wine,tobacco habit and susceptibility in primary liver cancer. Journal of Guangxi Medical Unversity 25.</mixed-citation>
</ref>
<ref id="pone.0057043-Long3">
<label>67</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Long</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>ZL</given-names></name> (<year>2005</year>) <article-title>A study about the association of detoxication gene GSTM1 polymorphism and the susceptibility to aflatoxin B1-related hepatocellular carcinoma</article-title>. <source>Chinese Journal of Hepatology</source> <volume>13</volume>: <fpage>668</fpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Deng3">
<label>68</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Deng</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>Y</given-names></name> (<year>2001</year>) <article-title>Glutathione-S-transferase M1 genotype in patients with hepatocellular carcinoma</article-title>. <source>Chinese Journal of Oncology</source> <volume>23</volume>: <fpage>477</fpage>–<lpage>479</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Wei2">
<label>69</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wei</surname><given-names>YP</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>ZL</given-names></name> (<year>2004</year>) <article-title>Genetic polymorphisms of Glutathione S-transferase M1 and T1 and the risk of hepatocellular carcinoma</article-title>. <source>Tumor</source> <volume>23</volume>: <fpage>464</fpage>–<lpage>466</lpage>.</mixed-citation>
</ref>
<ref id="pone.0057043-Wei3">
<label>70</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wei</surname><given-names>YP</given-names></name>, <name name-style="western"><surname>Long</surname><given-names>XD</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>CZ</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>ZL</given-names></name> (<year>2010</year>) <article-title>Genetic polymorphism of glutathione-S-transferase M1 and T1 in associated with carcinogenesis of hepatocellular carcinoma and nasopharyngeal carcinoma</article-title>. <source>Cancer Research On Prevention And Treatment</source> <volume>37</volume>: <fpage>1162</fpage>–<lpage>1165</lpage>.</mixed-citation>
</ref>
</ref-list>
</back>
</article>